[{"text": "PREMIUM Collegium Pharmaceutical Insider Sold Shares Worth $908,628, According to a Recent SEC Filing MT Newswires Wed, Jan 15, 2025, 12:17 AM In This Article: COLL Shirley R. Kuhlmann, Executive Vice President and General Counsel, on January 10, 2025, sold 27,500 PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-15T00:17:57", "sentiment": {"score": 0.028614500537514687, "confidence": 0.043551065027713776, "probabilities": {"positive": 0.043551065027713776, "negative": 0.014936564490199089, "neutral": 0.941512405872345}}, "embedding": [-0.10059867054224014, -0.11182566732168198, -0.07880695164203644, 0.09785808622837067, -0.03159232810139656, -0.02896534465253353, 0.005704059731215239, 0.2942623496055603, 0.08366206288337708, -0.06013422831892967, -0.07519272714853287, 0.1415146142244339, 0.09405006468296051, -0.025461241602897644, -0.06757429987192154, -0.01830996386706829, 0.08947310596704483, -0.06470370292663574, -0.08262388408184052, -0.014222437515854836, -0.2316192239522934, -0.07635867595672607, -0.05485865846276283, 0.016564643010497093, 0.16289938986301422, 0.14082121849060059, -0.03349654749035835, -0.14783748984336853, 0.03354516625404358, -0.05294418707489967, 0.05077103525400162, 0.0029660440050065517, 0.021155182272195816, 7.833910058252513e-05, 0.04592215269804001, -0.07207663357257843, -0.1283770054578781, 0.0946112647652626, 0.09786371141672134, -0.04841489717364311, 0.03957788273692131, -0.05921107158064842, -0.0736033096909523, 0.03303730487823486, -0.06701663881540298, -0.14422555267810822, -0.11994090676307678, 0.1168305054306984, 0.11887560784816742, 0.14847500622272491, -0.12549984455108643, -0.08791206777095795, 0.08006410300731659, 0.008218501694500446, -0.01390820648521185, 0.0276351235806942, -0.18201042711734772, -0.04703838750720024, 0.04668360576033592, 0.030733009800314903, 0.05250951275229454, -0.042992811650037766, 0.01729445345699787, -0.008827732875943184, -0.02272142469882965, 0.004635707009583712, 0.02535390481352806, -0.09069380164146423, 0.03774888813495636, -0.02951161190867424, 0.13435646891593933, 0.1264197826385498, 0.033467404544353485, -0.04337436705827713, -0.06339409202337265, 0.0852467492222786, 0.04377545788884163, -0.04803663119673729, -0.005190995521843433, -0.020041244104504585, 0.07696838676929474, 0.05501633882522583, -0.019755898043513298, 0.03314497694373131, 0.056043073534965515, -0.0092031080275774, 0.16860102117061615, 0.06714184582233429, 0.05774573236703873, -0.07997548580169678, 0.11292953789234161, -0.028862956911325455, -0.12298821657896042, -0.12930244207382202, -0.234894797205925, 0.181740865111351, -0.1566874384880066, 0.016181128099560738, -0.09847976267337799, 0.04030301049351692, 0.10643229633569717, -0.021556535735726357, 0.007725299336016178, -0.07082584500312805, -0.06315325945615768, -0.06613723933696747, 0.07137759029865265, 0.06227947399020195, -0.06702519953250885, 0.002816068707033992, -0.06932967901229858, 0.01710391417145729, -0.1395435333251953, -0.04269684851169586, 0.047286633402109146, 0.03640877828001976, 0.011864665895700455, -0.025380413979291916, 0.09742540121078491, -0.11352133005857468, 0.03635480999946594, 0.022909507155418396, -0.08317263424396515, 0.01111009530723095, -0.01456963550299406, -0.08840398490428925, -0.02728874795138836, 1.1767560970711014e-32, 0.017804404720664024, 0.050186555832624435, 0.025997977703809738, -0.04267501085996628, 0.012952710501849651, 0.04504583775997162, 0.1684224009513855, -0.07388408482074738, -0.1628599613904953, 0.011725295335054398, -0.15427343547344208, 0.18390566110610962, -0.05194593593478203, -0.037210799753665924, -0.09990295767784119, -0.04964250326156616, 0.01729239895939827, -0.01283789798617363, 0.0716080293059349, -0.14216363430023193, 0.11363507062196732, 0.08428385853767395, -0.059483326971530914, 0.14797931909561157, -0.1804838478565216, 0.12690261006355286, 0.011943318881094456, -0.00582193024456501, 0.16166558861732483, 0.05291542410850525, -0.09490074962377548, 0.10049723833799362, 0.023821044713258743, 0.10629881173372269, 0.006315428763628006, 0.10517282038927078, -0.13623513281345367, -0.08670809864997864, 0.11342735588550568, 0.03561731055378914, -0.03679096698760986, 0.14173364639282227, -0.010380979627370834, -0.19782380759716034, -0.07117851823568344, 0.011203227564692497, -0.11799091845750809, 0.06412871181964874, 0.11298302561044693, -0.1964457631111145, -0.07252396643161774, 0.09411035478115082, -0.0848509818315506, 0.06443369388580322, -0.07979830354452133, 0.0179764237254858, 4.9509810196468607e-05, 0.035638220608234406, 0.15942245721817017, 0.05674203112721443, 0.027405887842178345, 0.11877979338169098, -0.04335448518395424, 0.05814942345023155, -0.23558223247528076, 0.197981059551239, -0.18322694301605225, -0.041227445006370544, -0.04086727648973465, 0.12569068372249603, 0.0618150420486927, 0.05928737297654152, -0.010066800750792027, -0.05308731272816658, 0.04632486775517464, -0.026118941605091095, 0.026322482153773308, -0.06239084154367447, 0.17387965321540833, 0.18838265538215637, 0.048625342547893524, -0.07512974739074707, 0.000309952039970085, 0.1678631603717804, -0.004267320968210697, 0.013967739418148994, -0.14794550836086273, 0.10201600193977356, -0.022695939987897873, 0.05095513164997101, 0.04404176026582718, -0.08297310769557953, -0.04712460935115814, 0.11521538347005844, -0.01664259284734726, -1.1640360727008534e-32, -0.031967490911483765, -0.0051191458478569984, 0.09970814734697342, -0.07386370748281479, -0.06652560085058212, 0.07233972102403641, -0.06639926880598068, 0.12114500254392624, -0.007968440651893616, 0.07642746716737747, 0.05026543140411377, 0.16888433694839478, -0.0713915005326271, 0.0923110693693161, -0.09622306376695633, 0.039502594619989395, 0.05824477970600128, -0.04350379481911659, 0.04926711320877075, -0.08192819356918335, -0.12359198182821274, 0.14705641567707062, 0.024775274097919464, 0.25701451301574707, 0.06759148091077805, 0.013817145489156246, 0.1365688145160675, 0.09542256593704224, 0.012915195897221565, 0.11165700852870941, -0.026622049510478973, -0.004021447617560625, -0.10888922214508057, -0.03121148981153965, -0.06519945710897446, -0.08756814152002335, 0.08152570575475693, -0.06463310122489929, 0.05918536335229874, -0.06640756875276566, 0.00798057857900858, -0.047603871673345566, 0.1433388739824295, 0.0779360681772232, 0.24228909611701965, -0.1394253373146057, -0.022743161767721176, -0.17558151483535767, 0.11841331422328949, 0.016634169965982437, 0.022948695346713066, -0.012498414143919945, 0.07265713065862656, 0.07682625204324722, -0.1471746563911438, 0.03322463855147362, -0.047697361558675766, 0.02410099282860756, 0.18134742975234985, -0.10431534051895142, -0.012921787798404694, 0.19682522118091583, -0.19835853576660156, -0.008556139655411243, -0.06649059802293777, 0.08402194827795029, -0.024074573069810867, -0.01177850179374218, -0.11039654165506363, -0.07581070810556412, 0.040407806634902954, -0.20822253823280334, 0.06902381777763367, -0.1661672294139862, 0.09263159334659576, 0.17417791485786438, -0.09968651086091995, 0.039806243032217026, -0.0017823283560574055, 0.18640512228012085, 0.012806572020053864, -0.13026078045368195, 0.0577688105404377, -0.0832563191652298, -0.06840723752975464, -0.0536675900220871, 0.05816887691617012, 0.03493105620145798, -0.06533660739660263, 0.05200190842151642, -0.18274231255054474, -0.0727100521326065, -0.024343568831682205, 0.013584005646407604, 0.16846054792404175, -9.94758693195763e-08, -0.00731598911806941, 0.005917773582041264, -0.01296677254140377, 0.06547217071056366, 0.10956111550331116, -0.024386035278439522, 0.014895832166075706, -0.009366250596940517, -0.024100782349705696, 0.19662787020206451, -0.07340444624423981, -0.02146998606622219, -0.1283872276544571, 0.018744057044386864, -0.18320882320404053, 0.0893477350473404, -0.025550343096256256, -0.021655989810824394, 0.12735101580619812, -0.04561329632997513, 0.08942341804504395, 0.03924586996436119, 0.18009741604328156, -0.08516594767570496, -0.1083725318312645, 0.043874021619558334, -0.05189625173807144, -0.08114174008369446, -0.03753777593374252, 0.029510846361517906, -0.024699531495571136, 0.006348143331706524, 0.07080920785665512, 0.10423541814088821, 0.05789327248930931, 0.039606526494026184, -0.008619897067546844, 0.0317450575530529, -0.08295317739248276, 0.0913156196475029, -0.023783206939697266, -0.01688726805150509, -0.04421333968639374, -0.013266364112496376, -0.01912090554833412, 0.07162387669086456, -0.205190971493721, -0.07777804136276245, 0.06310920417308807, -0.11407774686813354, 0.1354302167892456, -0.08130716532468796, -0.08354976773262024, 0.002167115453630686, -0.05837726965546608, -0.00851153489202261, -0.011281502433121204, -0.07000891864299774, -0.2580677568912506, -0.12568072974681854, -0.10538147389888763, -0.2877596318721771, -0.04305673763155937, 0.055343471467494965], "changes": {"1wk": 0.030133578786144487}}, {"text": "Welcome to the Costa Blanca: pro cycling's winter getaway Jacques KLOPP Tue, Jan 14, 2025, 9:56 AM 4 min read Tadej Pogacar training with his UAE team-mates in the Benidorm region (JOSE JORDAN) Dubbed a \"motorway for cyclists\" where avid amateurs can chase Tadej Pogacar up mountains teeming with the highest concentration of professional cyclists per square mile in the world, Spain's Costa Blanca has forged a new reputation for itself in recent years. Long known as the ideal summer destination for those in search of sun, sea and sand, the stretch of coast between Valencia and Alicante now has a winter vocation too. During the season break in December and January, the region experiences an invasion of cyclists. Star names such as three-time Tour de France winner Pogacar, Remco Evenepoel and Julian Alaphilippe flock to the south-east of Spain to take advantage of the Costa's Mediterranean climate, its little-used roads and its bustling seaside hospitality sector that rolls out the red carpet for them from Calpe to Benidorm. Sixteen of the 18 men's World Tour teams have set up their winter quarters there to prepare for the new season, with some riders staying on privately between camps to take advantage of the conditions. Belgian double Olympic gold medallist Evenepoel has even bought an apartment in the area. \"Within a 50-kilometre radius, 80 percent of the peloton is here at the same time in December and January, and sometimes even in February. It's quite unique,\" Philippe Mauduit, race director of the Groupama-FDJ team, told AFP. Add in the women's teams, outfits from lower divisions and even the juniors, and it can all build quickly into a traffic jam. \"Just yesterday we were doing tests on the Coll de Rates. It was like a motorway for cyclists, there were cyclists everywhere,\" said Spanish rider Alex Aranburu, a new arrival at Cofidis. \"Sometimes it's hard to do the exercises because it's so crowded,\" added Frenchman Valentin Paret-Peintre of Soudal Quick-Step. \"There are other cool places to ride in Spain. But everyone comes here. It's fashionable.\" - 'Can we see the pros?' - Rush hour on the Coll de Rates -- where Pogacar just set the record ascent -- looks like a scene from downtown Manhattan. As the pros go rhythmically up and down the hill as part of their training exercises, they are tracked by bands of enthusiastic amateurs keen to see their favourite riders. \"They get into the peloton, they follow as long as they can, they turn around because they come across another team. For us, it's not disruptive. On the contrary, it creates a nice atmosphere,\" says Mauduit. The same point is highlighted by organisers of local cycling tours. Story Continues \"I get a lot of people writing to me asking if it's possible to see the pros,\" said Iliana Roumenova Ilkova, a former Bulgarian professional ballerina who set up Paradisebike13 to guide enthusiasts around Calpe. \"As I know a few of the riders, they tell me where they're going, so I arrange for us to be there too. The other day we ran into Pogacar and Alaphilippe, who said hello to me.\" For Ilkova, the reasons for the area's success are obvious: \"The weather, the beautiful scenery and safe roads with respectful motorists who know that cycling tourism is important for the local economy.\" But there is a flip-side to this vast influx of cyclists. In the village of Parcent, nestled at the foot of the Coll de Rates, \"property prices have doubled\", she said. - 'Rooms with sea views' - Hoteliers down by the coast are rubbing their hands, however. Thanks to the arrival of cyclists, bolstering the traditional numbers of British and Dutch retirees, accommodation providers are able to stay open all year. \"We're made very welcome, with beautiful rooms with sea views, a very high standard of catering, meeting rooms, and all this at attractive rates,\" said Mauduit. \"And that helps them (hoteliers) to maintain the employment pool,\" he added. The Groupama-FDJ race director also pointed to the Costa Blanca's accessibility as another advantage. \"We're halfway between Valencia and Alicante, so that gives you a range of low-cost flights. In December, 120 people go. If you pay 60 euros ($61) for your plane ticket instead of 600 euros, it's a great help for your budget.\" In Calpe, there are often several teams staying in the same hotels, which is not necessarily to the liking of all the pros. But for Paret-Peintre this means he can go riding and have a coffee with friends. \"In competition, I'll do everything I can to beat them,\" insisted the 23-year-old rider. \"But in training or at the hotel, they are first and foremost colleagues.\" jk/gk/nf/gj View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-14T09:56:47", "sentiment": {"score": 0.013219445943832397, "confidence": 0.0683707445859909, "probabilities": {"positive": 0.0683707445859909, "negative": 0.05515129864215851, "neutral": 0.8764778971672058}}, "embedding": [0.0125797800719738, 0.10357819497585297, -0.01214705128222704, 0.044486016035079956, 0.05918482691049576, 0.009865818545222282, 0.15306398272514343, 0.037569522857666016, 0.06790480017662048, -0.005420966073870659, 0.045021768659353256, -0.11572873592376709, 0.062028221786022186, 0.07050848007202148, 0.15924057364463806, 0.013378064148128033, 0.03214545175433159, -0.10515349358320236, -0.0026123225688934326, 0.08557020127773285, 0.025481758639216423, -0.20061516761779785, -0.043306224048137665, 0.016838129609823227, -0.13546018302440643, -0.09283703565597534, -0.0795331597328186, 0.04966770112514496, -0.21011999249458313, -0.08269242942333221, -0.08725124597549438, 0.2475639283657074, 0.03589753061532974, -0.07206523418426514, -0.05978184565901756, 0.047923311591148376, 0.06414832174777985, 0.019656669348478317, -0.12880975008010864, 0.04635494947433472, -0.04273846000432968, -0.034859783947467804, -0.08369801938533783, 0.06927160918712616, 0.05209139734506607, -0.06072027236223221, 0.15764664113521576, 0.05621011182665825, -0.027334026992321014, 0.0016210135072469711, 0.027771100401878357, -0.03244460001587868, 0.05021895840764046, -0.03204254060983658, -0.09883272647857666, -0.05580369383096695, -0.04268203675746918, 0.003790693823248148, 0.08226647973060608, -0.013512806966900826, 0.07360672205686569, -0.10452838987112045, -0.14599448442459106, 0.008155369199812412, -0.04867706447839737, -0.09993758797645569, 0.038745928555727005, -0.008493754081428051, -0.07834278792142868, 0.06165805459022522, 0.013701989315450191, 0.03869718313217163, -0.08413508534431458, -0.0627661719918251, 0.09490084648132324, 0.09297047555446625, -0.026306694373488426, 0.034732669591903687, -0.09459007531404495, -0.14316590130329132, 0.01268627867102623, -0.11291094124317169, 0.01755966618657112, -0.009562280029058456, 0.11385385692119598, -0.132732093334198, 0.13573309779167175, -0.033114127814769745, 0.14336740970611572, -0.0444403700530529, -0.07999342679977417, 0.08228826522827148, -0.12724976241588593, 0.08919133245944977, -0.052290067076683044, 0.09474463760852814, 0.0261508971452713, 0.15892820060253143, -0.02324286475777626, 0.07895693928003311, 0.11130674183368683, 0.041546113789081573, 0.09973414987325668, -0.02194809913635254, -0.08363853394985199, 0.04331119358539581, 0.07591824978590012, 0.03666304051876068, 0.0015757419168949127, -0.02354171872138977, -0.12538376450538635, 0.05899667367339134, 0.10790543258190155, -0.06291671842336655, -0.1350124627351761, 0.11176812648773193, -0.12101364880800247, 0.014759758487343788, 0.08064214140176773, 0.0813002735376358, -0.06553464382886887, 0.07032491266727448, -0.0324450321495533, 0.17236264050006866, 0.20093420147895813, 0.011798566207289696, 0.10244031995534897, 7.640016799942007e-33, -0.026065237820148468, 0.028993885964155197, 0.008216730318963528, -0.0006529465317726135, 0.1253056675195694, -0.014177851378917694, -0.06862283498048782, -0.05150024965405464, -0.04000234976410866, -0.09896918386220932, 0.01722038723528385, -0.023420589044690132, 0.02167324349284172, 0.042967788875103, 0.1726793497800827, 0.01830742135643959, -0.04633648693561554, -0.09801462292671204, -0.06548243016004562, 0.03036276251077652, 0.07432830333709717, 0.03511231765151024, -0.018972953781485558, 0.0352165661752224, 0.026701416820287704, 0.2410200834274292, 0.11713442206382751, -0.06995672732591629, 0.002501412993296981, 0.10227334499359131, -0.011931345798075199, -0.07957054674625397, -0.008668296039104462, 0.11315075308084488, 0.002573898294940591, 0.022226396948099136, -0.008658611215651035, -0.028125768527388573, -0.10329296439886093, 0.09441907703876495, -0.026436539366841316, -0.12194107472896576, -0.08935531973838806, -0.030098363757133484, -0.07664474844932556, -0.09611587971448898, 0.08244843780994415, 0.1946696788072586, -0.04283292591571808, 0.10637250542640686, -0.08862912654876709, 0.002781664952635765, -0.03603881597518921, -0.08492162823677063, -0.0239083431661129, 0.10132705420255661, -0.09370939433574677, 0.05981886014342308, -0.056239768862724304, 0.08704832941293716, 0.019806304946541786, 0.10585547983646393, 0.02645375393331051, 0.05326031520962715, -0.11613483726978302, -0.03230944275856018, 0.02289746329188347, -0.020270027220249176, 0.02465279959142208, -0.046566348522901535, -0.046994999051094055, 0.012670330703258514, 0.1711162030696869, 0.042730290442705154, 0.11783784627914429, -0.05028354749083519, -0.025456365197896957, 0.04527115076780319, 0.01850391924381256, 0.038145411759614944, -0.14755059778690338, -0.02390521951019764, -0.08041010797023773, -0.09695658832788467, -0.14302054047584534, 0.011022062972187996, 0.1698245257139206, -0.0557798370718956, -0.1079571396112442, 0.0054936339147388935, -0.0791216567158699, -0.03113054297864437, 0.06664502620697021, 0.0020918846130371094, 0.023133650422096252, -7.698161158637493e-33, 0.036238472908735275, -0.07585018873214722, 0.1844186782836914, -0.06609606742858887, 0.11805614084005356, 0.07837066799402237, 0.12350764870643616, -0.04076393321156502, -0.0831800252199173, -0.05143662542104721, -0.14041867852210999, -0.09926089644432068, 0.07730408757925034, -0.08726654946804047, -0.051392532885074615, 0.03210165351629257, 0.11736352741718292, 0.013235082849860191, -0.1487218141555786, -0.002490350976586342, -0.055898942053318024, 0.03392063453793526, -0.03906833380460739, 0.013654062524437904, -0.05608935281634331, 0.05257750302553177, 0.07371126115322113, 0.07130447030067444, -0.07328888773918152, 0.03924501687288284, -0.20058907568454742, 0.06031139940023422, -0.15298156440258026, -0.06872861087322235, -0.11309218406677246, 0.18366771936416626, -0.1879088282585144, 0.09758594632148743, -0.06064304709434509, 0.17318685352802277, -0.030867906287312508, -0.12561139464378357, -0.030439965426921844, 0.0020467652939260006, 0.04036155715584755, 0.050560928881168365, -0.014528957195580006, -0.0626225396990776, -0.02433750592172146, -0.05892666056752205, 0.14775200188159943, 0.0680503249168396, -0.19080772995948792, 0.023809019476175308, 0.12448206543922424, 0.015127274207770824, -0.10956759750843048, -0.09316310286521912, -0.1251695156097412, -0.08875791728496552, 0.007550839334726334, 0.0854426771402359, 0.026438631117343903, 0.07997246086597443, 0.07645723223686218, -0.05057086795568466, -0.1356000006198883, -0.04571089893579483, -0.04750324785709381, 0.10320469737052917, -0.0679156705737114, -0.01855430193245411, -0.20399357378482819, -0.09608493745326996, -0.10735426098108292, 0.10487768054008484, -0.021664611995220184, 0.028622537851333618, -0.033966775983572006, -0.07048124074935913, -0.12087662518024445, -0.08532170951366425, 0.004996567964553833, 0.03382006660103798, 0.04150325432419777, 0.0258486308157444, -0.09086312353610992, -0.04367183893918991, 0.08519239723682404, 0.05955579876899719, 0.08636576682329178, 0.05950932204723358, -0.11353100836277008, 0.04834657162427902, 0.006199034862220287, -1.0046649379091832e-07, 0.0400332547724247, 0.04324584826827049, -0.06455483287572861, 0.0060201771557331085, 0.06544233113527298, -0.12366137653589249, 0.0551920160651207, 0.09688439965248108, -0.0992836132645607, 0.21737223863601685, 0.21314510703086853, 0.06571822613477707, 0.08383305370807648, 0.07764845341444016, 0.025526979938149452, 0.0743916779756546, 0.0382801778614521, 0.08573945611715317, -0.12583152949810028, -0.03148801252245903, -0.09525373578071594, 0.0026496928185224533, -0.10212893784046173, 0.03403851389884949, 0.10598871111869812, -0.06603147834539413, -0.07258877903223038, -0.037062160670757294, 0.15101967751979828, -0.11580979824066162, -0.07737962901592255, -0.06834123283624649, -0.03001847118139267, -0.08174731582403183, 0.1115533709526062, 0.03243543580174446, 0.00015046633780002594, 0.07632236182689667, -0.005720741115510464, 0.09471943974494934, -0.00780834723263979, -0.014674767851829529, 0.020999792963266373, 0.034377165138721466, 0.05889604985713959, -0.05350702255964279, -0.1310397982597351, -0.029068555682897568, -0.0421842560172081, 0.006581718102097511, -0.1272154450416565, -0.05707171559333801, -0.0031796451658010483, 0.07001329213380814, 0.02452666684985161, 0.1591339111328125, -0.17174585163593292, -0.1610158383846283, -0.03453012555837631, 0.15890318155288696, -0.08570730686187744, 0.010418476536870003, -0.048588115721940994, -0.03592640906572342], "changes": {"1wk": 0.5123513182089824}}, {"text": "PREMIUM Needham Upgrades Collegium Pharmaceutical to Buy From Hold, Price Target is $46 MT Newswires Fri, Jan 10, 2025, 4:28 PM In This Article: COLL Collegium Pharmaceutical (COLL) has an average rating of buy and mean price target of $43, according PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-10T16:28:01", "sentiment": {"score": 0.0241282619535923, "confidence": 0.04058011248707771, "probabilities": {"positive": 0.04058011248707771, "negative": 0.016451850533485413, "neutral": 0.9429680705070496}}, "embedding": [-0.10192906111478806, -0.22744202613830566, -0.07320105284452438, 0.09752357006072998, 0.08908569067716599, -0.07709544897079468, -0.11909423023462296, 0.26656511425971985, 0.10773266851902008, -0.07096006721258163, -0.06133965775370598, 0.07665999978780746, 0.03229088336229324, -0.05894700065255165, 0.019977424293756485, -0.06639765202999115, 0.13092932105064392, -0.1152118593454361, -0.049620773643255234, 0.07440002262592316, -0.16698753833770752, 0.01205513346940279, -0.061664752662181854, 0.01113508827984333, 0.038924314081668854, 0.07350321859121323, -0.10618819296360016, -0.031747665256261826, 0.08264905959367752, -0.05304795876145363, -0.014767684042453766, 0.11358453333377838, -0.00676343496888876, -0.08776300400495529, 0.0533718466758728, -0.09385234117507935, -0.09818688780069351, 0.05646245554089546, 0.008452956564724445, 0.05599359795451164, 0.002706259023398161, -0.11743150651454926, -0.1559886485338211, 0.030133428052067757, -0.060865823179483414, -0.16339083015918732, -0.13640598952770233, 0.22291231155395508, 0.11774720251560211, 0.23170803487300873, -0.15700386464595795, -0.14316709339618683, 0.06867364794015884, -0.0706324428319931, -0.14194007217884064, 0.060758285224437714, -0.1433538943529129, 0.002061037812381983, 0.08355886489152908, -0.026431474834680557, -0.11639484018087387, -0.07464560121297836, -0.08266860991716385, 0.0005511721246875823, 0.013136381283402443, 0.004175894893705845, -0.016903458163142204, -0.11313380300998688, 0.021715568378567696, 0.03765333816409111, -0.0498235747218132, 0.05874209851026535, 0.2248126119375229, -0.013291163370013237, 0.04913872480392456, 0.17677341401576996, 0.10120689868927002, -0.14142011106014252, 0.06840617209672928, 0.04882791265845299, 0.06332103163003922, -0.08414794504642487, -0.1060677245259285, -0.05048158019781113, 0.1556999385356903, -0.11563620716333389, 0.3176763951778412, 0.15044662356376648, 0.0907396748661995, -0.0828932449221611, 0.1428755819797516, 0.05085637420415878, -0.2261684387922287, -0.1272277534008026, -0.22444894909858704, 0.1557902842760086, -0.09184734523296356, 0.00604160176590085, -0.11915505677461624, -0.0009825623128563166, 0.11558840423822403, -0.08593500405550003, 0.0581815168261528, -0.09136231243610382, -0.1562187373638153, -0.17448173463344574, -0.0009398561669513583, 0.13149549067020416, -0.008424927480518818, -0.06103521212935448, -0.03121681697666645, -0.016780711710453033, -0.10958625376224518, -0.12719181180000305, -0.08099377900362015, 0.07672363519668579, -0.1358667016029358, -0.21778328716754913, 0.10902491956949234, -0.24195407330989838, -0.04693515971302986, 0.03174452856183052, -0.0259690098464489, -0.07526985555887222, -0.13969625532627106, -0.14269722998142242, 0.05153299495577812, 1.0619579065169722e-32, -0.11468981206417084, 0.03450072184205055, -0.17646627128124237, -0.1850239336490631, -0.13871316611766815, -0.08388113230466843, 0.19298860430717468, 0.027689073234796524, -0.25308847427368164, -0.01834811456501484, -0.0415816567838192, 0.11041701585054398, -0.1583952158689499, -0.005157979670912027, -0.02290552482008934, -0.12240413576364517, 0.15681032836437225, 0.09339097887277603, 0.0493047758936882, -0.02494669146835804, 0.053904153406620026, 0.018055593594908714, -0.07980755716562271, 0.14972928166389465, -0.06715542823076248, 0.2102491557598114, 0.04489240422844887, 0.01785949058830738, 0.2801639139652252, 0.05098751559853554, -0.06257181614637375, 0.10849642753601074, 0.13310840725898743, 0.04874119535088539, -0.025988290086388588, 0.038195107132196426, -0.13378965854644775, -0.12782537937164307, 0.06715784966945648, -0.15452268719673157, 0.017246071249246597, 0.1865953952074051, -0.07014963775873184, -0.03614794462919235, -0.03759131208062172, -0.010170483030378819, -0.07558698207139969, -0.09482204914093018, -0.08107519149780273, -0.2032671719789505, -0.14190764725208282, 0.13213078677654266, -0.18514052033424377, 0.2204131782054901, -0.1298818141222, -0.12566761672496796, -0.08652045577764511, 0.050619978457689285, 0.2028278261423111, 0.06208738312125206, 0.027135659009218216, 0.009317978285253048, 0.012086724862456322, 0.018930090591311455, -0.1089714989066124, 0.17124848067760468, -0.17872150242328644, -0.06336740404367447, -0.06875921785831451, 0.19988253712654114, 0.14231707155704498, 0.10775601118803024, 0.003110446035861969, 0.02854432538151741, 0.15230441093444824, -0.0504593588411808, -0.01817796565592289, 0.04556145519018173, 0.23165006935596466, 0.13927118480205536, 0.08204721659421921, -0.09424487501382828, -0.12600280344486237, 0.07545501738786697, -0.03479748219251633, 0.030890226364135742, -0.12125524133443832, 0.024050097912549973, -0.11568046361207962, -0.010231487452983856, -0.021993538364768028, -0.07657087594270706, -0.12822581827640533, 0.15437079966068268, 0.15843407809734344, -1.2587844438601822e-32, 0.01992199942469597, -0.049107689410448074, 0.27308210730552673, 0.13076874613761902, -0.05191953107714653, 0.15208305418491364, -0.13477937877178192, 0.03930853679776192, 0.18470557034015656, 0.14616164565086365, -0.04182969778776169, 0.1401011049747467, -0.10679793357849121, 0.15824811160564423, -0.15451358258724213, 0.02872125431895256, 0.04385771602392197, -0.12299194186925888, 0.050688620656728745, -0.02319118194282055, -0.07262331992387772, 0.1895107477903366, 0.016965238377451897, 0.2365441471338272, -0.005247778259217739, 0.02671949565410614, 0.09917473047971725, 0.044108059257268906, -0.04217267036437988, 0.13381586968898773, -0.11052192002534866, 0.023267362266778946, -0.12273699045181274, 0.020886365324258804, -0.10022091120481491, 0.008458463475108147, 0.20376445353031158, 0.045547179877758026, -0.026462441310286522, 0.06549935042858124, 0.03586911782622337, -0.08152717351913452, 0.08785856515169144, -0.021815253421664238, 0.26692381501197815, -0.16056670248508453, 0.05645602196455002, -0.042208798229694366, 0.23372645676136017, -0.01804107427597046, -0.0012213835725560784, 0.06613324582576752, 0.06415750831365585, 0.0023739098105579615, -0.17457221448421478, 0.05874353647232056, -0.0417260117828846, -0.08094974607229233, 0.036419034004211426, -0.14331519603729248, 0.026922615244984627, 0.21937821805477142, -0.1854480504989624, -0.11379819363355637, 0.11500226706266403, 0.2877948582172394, 0.049908559769392014, -0.009003354236483574, -0.035173919051885605, 0.02649306319653988, -0.004490152467042208, -0.12988902628421783, 0.22601808607578278, -0.07200779020786285, 0.07905765622854233, 0.03761065751314163, 0.02656276896595955, 0.015708375722169876, 0.015250136144459248, 0.00797282624989748, 0.025278761982917786, -0.16284485161304474, -0.007825637236237526, -0.11940272152423859, -0.03705495595932007, -0.12055812031030655, 0.13542234897613525, 0.0665728896856308, -0.19009368121623993, 0.083407461643219, -0.2312062680721283, 0.011928177438676357, -0.039240386337041855, 0.0005269348621368408, 0.12145998328924179, -9.968308489760602e-08, -0.049294523894786835, 0.044616200029850006, -0.016330314800143242, 0.16474314033985138, 0.17053020000457764, 0.09511490911245346, -0.004489111714065075, -0.0011945420410484076, 0.08221368491649628, 0.20965392887592316, -0.08887893706560135, 0.10497190803289413, -0.1026269868016243, 0.013733175583183765, -0.3096015453338623, 0.08593263477087021, -0.06466056406497955, -0.019512247294187546, 0.11292261630296707, -0.17870911955833435, 0.07896199077367783, 0.028874671086668968, 0.3182949721813202, -0.08386082202196121, -0.05261510610580444, 0.024061862379312515, 0.012568469159305096, 0.04615440592169762, -0.046900294721126556, -0.04306980222463608, -0.055765483528375626, 0.030766868963837624, 0.21082119643688202, 0.03329853340983391, 0.19258621335029602, -0.036245498806238174, -0.17448148131370544, 0.12451694160699844, 0.0030302368104457855, 0.04455382376909256, 0.07180205732584, -0.029326293617486954, -0.11609398573637009, -0.03249083831906319, -0.08802683651447296, 0.08463126420974731, -0.3252066671848297, -0.05887448415160179, 0.07726260274648666, -0.10209817439317703, 0.03428168222308159, -0.08006338030099869, 0.0020657095592468977, 0.06771404296159744, 0.024640651419758797, -0.0076300716027617455, 0.05327141657471657, -0.05727643147110939, -0.11297726631164551, -0.04679260402917862, 0.04936349391937256, -0.3388053774833679, 0.03212461620569229, 0.13246743381023407], "changes": {"1wk": 1.6712222412963527}}, {"text": "This North Jersey home where Richard Nixon headlined a rally is listed for $6.325M David M. Zimmer, NorthJersey.com Updated Sun, Jan 19, 2025, 11:53 PM 4 min read Nestled on a peaceful, tree-lined street in Montclair, 25 Prospect Ave. commands attention. The 10-bedroom neoclassical mansion was built 125 years ago by James Turner, a lifelong bachelor who moved his brothers, sister and mother in with him. A stockbroker by trade, Turner became a philanthropist and agricultural innovator, leaving a lasting imprint on Montclair and beyond. In its early years, the home welcomed members of the Wall Street elite, including Turner's father and brother, both named Coll J. Turner, the latter being a winner of both the New York Stock Exchange and Montclair Golf Club annual tournaments, reported The Montclair Times. Half a century later, it welcomed an estimated crowd of 4,000 to see then-Vice President Richard Nixon speak during a rally for U.S. Rep. Clifford Case. The 10-bedroom mansion at 25 Prospect Avenue in Montclair was listed for $6.325 million in January 2025. The 125-year-old home welcomed Richard Nixon to a 1954 rally and hosted performances by the New Jersey Symphony Orchestra. This month it was listed for $6.325 million by Jill Gimber of Prominent Properties Sotheby's International Realty-Montclair. Constructed in 1900, three years after the death of Turner's father, 25 Prospect Ave. was designed by the prominent neoclassical architect Frank Freeman. Based in Brooklyn, where Turner was born, Freeman by then had become known for his buildings in the borough, including the Herman Behr Mansion, the Eagle Warehouse and the Old Brooklyn Fire Headquarters. In addition to 10 bedrooms, the home includes 13 bathrooms. The formal living room is a showcase of the period\u2019s opulence and Turner's wealth, with intricate woodwork, wide-plank floors and expansive windows. Nearby, a large dining room provides a fitting space for family gatherings, while the library offers a quiet retreat from them. The 10-bedroom mansion at 25 Prospect Avenue in Montclair was listed for $6.325 million in January 2025. The 125-year-old home welcomed Richard Nixon to a 1954 rally and hosted performances by the New Jersey Symphony Orchestra. Set on nearly 2 acres, 25 Prospect Ave. features landscaped grounds with a swimming pool and a pair of three-bedroom guest houses. The main home boasts a serene master suite, with a large sitting room offering sweeping views of the property. The property was not Turner's only one in North Jersey. More than a decade after moving to Montclair, he began investing heavily in farmland in Wantage. There, his uncle and business partner, James Newbegin Jarvie, was also buying farmland under the banners of Belle Ellen and Newbegin farms. Jarvie, aka the \"Coffee King,\" was a partner in Arbuckle Brothers, the first company to popularize preroasted coffee. Turner, a graduate of Amherst College, was the company CEO before retiring in his mid-40s in 1906, according to records kept by the Heritage and Agriculture Association. Turner invested heavily in his farm, called Lusscroft, spending $500,000 between 1914 and 1930 to turn it into a model dairy farm, state records show. He built a country manor for himself and a lodge for his brother, William Turner. He also inherited several of Jarvie\u2019s estates, including the Sussex County farms, after Jarvie's death in 1929. Story Continues The 10-bedroom mansion at 25 Prospect Avenue in Montclair was listed for $6.325 million in January 2025. The 125-year-old home welcomed Richard Nixon to a 1954 rally and hosted performances by the New Jersey Symphony Orchestra. In 1931, Turner donated 1,050 acres, including the Lusscroft, Belle Ellen and Newbegin farms, to the state along with 250 Guernsey and Holstein cattle, the dairy facilities, tractors, a full array of farm equipment, employee cottages and some horses, according to state records. The land became the North Jersey Dairy Branch of the State Agricultural Experiment Station, where groundbreaking work was done in the fields of livestock breeding for nearly 40 years. Perhaps most notably, Enos J. Perry conducted the first successful artificial insemination experiments at Lusscroft in 1938. Today, Lusscroft is preserved as a 578-acre section of High Point State Park. Still standing are the Turner Mansion, dairy barns and a series of worker cottages. Turner died in 1935, but 25 Prospect Ave. stayed in his immediate family until the mid-1940s, when it was sold to Augustus C. Studer Jr., formerly of 66 Christopher St. in Montclair. The 10-bedroom mansion at 25 Prospect Avenue in Montclair was listed for $6.325 million in January 2025. The 125-year-old home welcomed Richard Nixon to a 1954 rally and hosted performances by the New Jersey Symphony Orchestra. A prominent attorney and partner in what was McCarter, English and Studer, president of the New Jersey State Bar Association and son of the first publisher of The Montclair Times, Studer turned the home into a cultural hub. Among its more notable events were performances by the New Jersey Symphony Orchestra and the political rally headlined by future President Nixon, The Montclair Times reported. Margot Studer, Augustus\u2019 wife, championed philanthropy and music as co-chair of Newark\u2019s Symphony Hall restoration project. She was also politically active and served as an elector for President Dwight D. Eisenhower, state records show. This article originally appeared on NorthJersey.com: NJ home with link to Richard Nixon, White House on market View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-18T05:50:23", "sentiment": {"score": 0.03512061759829521, "confidence": 0.056040577590465546, "probabilities": {"positive": 0.056040577590465546, "negative": 0.020919959992170334, "neutral": 0.923039436340332}}, "embedding": [0.0075796484015882015, 0.004244949668645859, -0.06357409060001373, 0.017055826261639595, -0.06266911327838898, -0.002581520937383175, -0.044352274388074875, 0.011311434209346771, -0.07265231013298035, -0.008340414613485336, -0.11009902507066727, 0.07340660691261292, 0.1813003122806549, 0.013246070593595505, 0.03591850399971008, 0.07912437617778778, 0.06350502371788025, -0.02018037810921669, 0.010991711169481277, 0.2036016285419464, 0.016250938177108765, -0.15384948253631592, -0.02421943098306656, -0.10992951691150665, 0.14819464087486267, 0.058012522757053375, -0.09888672828674316, 0.1572614312171936, -0.10740151256322861, 0.018934857100248337, 0.10171359032392502, 0.04075814038515091, 0.041981227695941925, -0.008053961209952831, 0.056671932339668274, -0.0504915788769722, 0.044384680688381195, 0.1892862617969513, 0.10517771542072296, -0.014152023009955883, 0.020314017310738564, 0.0566554069519043, 0.028060048818588257, -0.04365536943078041, -0.10331061482429504, -0.021317314356565475, 0.0014372479636222124, -0.0087444381788373, 0.1343209147453308, 0.060234133154153824, -0.07092541456222534, 0.028435630723834038, 0.024339793249964714, -0.1058889776468277, -0.04201015084981918, 0.1260436773300171, -0.06618787348270416, 0.0012902365997433662, 0.0020871353335678577, -0.08993840217590332, 0.10053939372301102, -0.1312529593706131, -0.05257844179868698, -0.06057918071746826, 0.029566671699285507, -0.016345128417015076, 0.008333209902048111, 0.010559004731476307, 0.03874277323484421, -0.1326373964548111, 0.19175821542739868, 0.13726557791233063, -0.09963411092758179, -0.10602615773677826, -0.024677671492099762, 0.08018223196268082, 0.0809028223156929, 0.05213969573378563, -0.07696422934532166, -0.10800325870513916, 0.0065838126465678215, -0.004388866480439901, -0.0507531464099884, 0.0103366170078516, -0.009781073778867722, 0.07083341479301453, -0.07129883766174316, 0.034402839839458466, 0.06414591521024704, -0.03520945459604263, -0.059367503970861435, -0.13974367082118988, -0.10166478157043457, -0.06233441084623337, -0.03461713716387749, 0.011045035906136036, -0.1434066891670227, 0.03592025488615036, -0.04776611179113388, 0.09116241335868835, 0.04296323284506798, 0.07000049948692322, 0.006779863499104977, -0.03787999600172043, -0.026281312108039856, 0.06107116490602493, 0.12903457880020142, 0.1922488957643509, -0.1326429694890976, 0.006449087988585234, -0.14141960442066193, 0.03560157120227814, 0.013022723607718945, -0.005729020107537508, -0.026036104187369347, 0.07608351111412048, 0.06106524169445038, 0.010980944149196148, 0.052491553127765656, -0.0641767606139183, 0.10434554517269135, 0.06953560560941696, 0.030049853026866913, 0.02944154664874077, -0.08307945728302002, -0.02850787155330181, 0.004861125722527504, 7.286514791923036e-33, -0.08015307784080505, 0.09191862493753433, -0.010170333087444305, 0.09540534019470215, 0.09530755877494812, 0.10085391998291016, 0.01280639786273241, 0.05812590569257736, 0.005005946848541498, -0.029475323855876923, 0.12724456191062927, 0.05518095940351486, 0.10586853325366974, -0.0601898729801178, -0.0030974047258496284, 0.04875301569700241, 0.002697514370083809, -0.06127186492085457, -0.03093389794230461, -0.16563886404037476, -0.0035499241203069687, 0.07861500233411789, 0.020392458885908127, 0.08632085472345352, -0.10949721932411194, -0.05488353222608566, -0.03266826272010803, 0.12677861750125885, -0.12512722611427307, 0.013718022033572197, -0.0624723806977272, -0.031642697751522064, 0.03851888328790665, 0.08002737164497375, 0.15724244713783264, -0.0315270870923996, -0.011656571179628372, -0.11354854702949524, 0.04785130172967911, -0.05656009912490845, -0.04841623455286026, 0.021578604355454445, -0.11569757014513016, 0.13370433449745178, -0.08368688821792603, 0.10041691362857819, 0.047114402055740356, 0.11733707040548325, 0.05791597068309784, -0.06539040803909302, -0.042268626391887665, 0.11810781806707382, -0.1831333041191101, -0.09995587170124054, -0.14679214358329773, -0.05585477873682976, -0.002334179589524865, 0.0221388079226017, 0.058636441826820374, -0.05587475001811981, 0.06766059249639511, 0.1791640818119049, -0.02398630604147911, 0.11401818692684174, -0.21226100623607635, 0.02849559858441353, -0.08281585574150085, 0.0962466448545456, -0.028732215985655785, 0.1071958988904953, 0.11221247166395187, -0.05203092098236084, 0.03275763988494873, -0.05121787637472153, 0.11769159138202667, 0.04168565571308136, -0.014676249586045742, 0.007239885628223419, 0.06868062913417816, -0.07401051372289658, -0.04806680977344513, 0.007029044441878796, 0.026994461193680763, 0.10147064924240112, -0.02861829474568367, -0.04979000985622406, 0.12166863679885864, 0.020903347060084343, 0.048144444823265076, 0.017721375450491905, 0.04235765337944031, -0.09163731336593628, 0.02677670679986477, -0.07615961879491806, -0.10862866044044495, -7.25901263221761e-33, -0.14672622084617615, -0.041903961449861526, -0.03305406868457794, -0.13578201830387115, -0.0027610280085355043, -0.024154942482709885, 0.02653566375374794, -0.0820663720369339, -0.06958018243312836, -0.10559361428022385, -0.02085348777472973, 0.06610420346260071, -0.01706821843981743, 0.11524161696434021, -0.03257687762379646, 0.04839421063661575, 0.03480923920869827, -0.0760234147310257, 0.01862967014312744, 5.801115185022354e-05, 0.07243557274341583, 0.12531080842018127, -0.07603319734334946, 0.07319174706935883, -0.07034782320261002, 0.06352125108242035, 0.03919270634651184, 0.08784694969654083, 0.03721662610769272, 0.11504361778497696, -0.10991153866052628, 0.03590521961450577, -0.06252032518386841, 0.013859082013368607, 0.07718215882778168, 0.09612783789634705, 0.017717313021421432, -0.09117688238620758, 0.015780173242092133, -0.07221853733062744, -0.023871488869190216, -0.06136978790163994, 0.01810299977660179, 0.02807558700442314, 0.12345585227012634, -0.044963374733924866, -0.06455129384994507, -0.1760677695274353, -0.014713295735418797, 0.08462344110012054, -0.09319509565830231, 0.08843952417373657, -0.08486396074295044, 0.06389482319355011, -0.04500181972980499, 0.02312265709042549, 0.03488263487815857, 0.08241918683052063, 0.07917410880327225, 0.06224854290485382, -0.08895991742610931, 0.15390971302986145, -0.028466004878282547, 0.05035695433616638, 0.10273268073797226, -0.060570769011974335, -0.047942161560058594, -0.0825049877166748, -0.14567920565605164, 0.00207477156072855, -0.12528279423713684, 0.018473250791430473, 0.0749645084142685, -0.04983885586261749, -0.16811442375183105, 0.12629389762878418, 0.17426882684230804, 0.05063225328922272, -0.06763807684183121, -0.04728817939758301, -0.09869248420000076, 0.0012030517682433128, -0.03726958855986595, -0.09741814434528351, 0.00518676545470953, 0.012888822704553604, -0.04685172811150551, -0.02072634920477867, -0.10853202641010284, -0.010403483174741268, 0.10856936126947403, -0.06887215375900269, 0.00022609997540712357, -0.10917454957962036, -0.01600780338048935, -1.0022776564255764e-07, -0.031162595376372337, 0.09252230823040009, 0.041981179267168045, 0.04999621957540512, 0.0165154617279768, -0.08055093884468079, 0.10805203765630722, -0.08794446289539337, 0.03162427991628647, 0.14932459592819214, 0.10613647103309631, 0.058535780757665634, 0.060263488441705704, -0.045471444725990295, -0.15168264508247375, -0.10879749059677124, -0.02367974817752838, -0.09190033376216888, -0.08565366268157959, 0.02377297542989254, 0.12021678686141968, 0.013261767104268074, -0.02025827020406723, 0.004929021932184696, 0.0741715133190155, -0.14130353927612305, -0.007172219920903444, -0.09807203710079193, -0.018811173737049103, -0.038765981793403625, -0.0032187053002417088, -0.022097095847129822, 0.03976360335946083, -0.09984715282917023, 0.08466576039791107, 0.0447218157351017, 0.06023117154836655, -0.0016579432412981987, 0.005622020456939936, -0.021593093872070312, -0.06594227254390717, -0.04740561544895172, -0.15267756581306458, -0.02830788493156433, 0.15411940217018127, -0.06910548359155655, -0.09191417694091797, -0.09702980518341064, 0.0668923556804657, -0.025028031319379807, -0.048725858330726624, 0.03670213371515274, 0.016908738762140274, -0.017947448417544365, 0.05817614495754242, -0.04240817204117775, -0.17855608463287354, 0.023264536634087563, -0.009736310690641403, 0.022585399448871613, 0.019674986600875854, -0.0010863740462809801, -0.08510372042655945, -0.023184102028608322], "changes": {"1wk": -1.8077689031245003}}, {"text": "PREMIUM Collegium Pharmaceutical Shares Rise After 2025 Guidance MT Newswires Wed, Jan 8, 2025, 8:17 PM In This Article: COLL Collegium Pharmaceutical (COLL) shares rose by nearly 13% in recent trading on Wednesday after the c PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-08T20:17:44", "sentiment": {"score": 0.14633991103619337, "confidence": 0.15688832104206085, "probabilities": {"positive": 0.15688832104206085, "negative": 0.010548410005867481, "neutral": 0.8325632810592651}}, "embedding": [-0.22054113447666168, -0.3166726231575012, -0.042481429874897, 0.1693735271692276, 0.07097582519054413, -0.04078535735607147, -0.2000134140253067, 0.190229132771492, 0.15039296448230743, -0.07854798436164856, -0.015849296003580093, 0.3168516159057617, 0.05463409051299095, 0.08691519498825073, -0.00546798761934042, -0.09281061589717865, 0.0034115174785256386, -0.09617946296930313, -0.15781059861183167, -0.02935403771698475, -0.2539105713367462, -0.2111828625202179, -0.042157404124736786, 0.05717095732688904, 0.1952538937330246, 0.09693141281604767, -0.07541371136903763, -0.07056945562362671, 0.021398641169071198, -0.047922782599925995, 0.004317580722272396, 0.09511828422546387, 0.10096240788698196, 0.008162351325154305, -0.03195932134985924, -0.16664698719978333, -0.14836733043193817, 0.02800397016108036, 0.15488873422145844, -0.011866148561239243, -0.0027102718595415354, -0.2361883819103241, -0.07060401141643524, 0.1619921177625656, -0.05602334812283516, -0.13247965276241302, -0.12317423522472382, 0.08080008625984192, 0.0507037416100502, 0.22944596409797668, -0.12935291230678558, -0.11252514272928238, 0.06323664635419846, -0.057311661541461945, -0.20198805630207062, 0.030446389690041542, -0.2543123662471771, -0.11837566643953323, 0.15509074926376343, 0.006015059072524309, -0.07891959697008133, -0.02278026007115841, -0.031392525881528854, 0.06492412090301514, -0.1021922156214714, 0.07409096509218216, 0.09070797264575958, 0.10132613033056259, -0.024661624804139137, 0.032366249710321426, 0.04100511968135834, 0.05980043113231659, 0.09411735087633133, 0.025337794795632362, -0.03429767116904259, 0.16419954597949982, 0.11867400258779526, -0.02233368530869484, 0.17661890387535095, -0.1383596807718277, 0.03790459409356117, 0.11179522424936295, -0.0809430256485939, 0.011036787182092667, -0.00561566511169076, -0.04918672516942024, 0.14889207482337952, 0.043255142867565155, -0.04366276413202286, -0.1885567307472229, 0.17191004753112793, 0.05398713797330856, -0.22568939626216888, 0.012393849901854992, -0.3310064375400543, 0.12619401514530182, -0.14239414036273956, -0.10950926691293716, -0.03342559561133385, 0.02997848391532898, 0.07896223664283752, 0.013167943805456161, -0.03278229758143425, -0.060713525861501694, -0.14428366720676422, -0.1585848480463028, 0.007473519537597895, 0.131055548787117, -0.029469773173332214, 0.02796240709722042, 0.026197761297225952, 0.09696567058563232, -0.14007902145385742, -0.10175321996212006, -0.1633426547050476, 0.17995969951152802, -0.0829702764749527, -0.081846222281456, 0.09451103955507278, -0.1066143810749054, -0.02541700378060341, 0.10497500747442245, -0.125983327627182, -0.04507799819111824, 0.021918658167123795, -0.04905417934060097, 0.0705612301826477, 1.2871514735342257e-32, -0.11360476166009903, 0.016018196940422058, -0.0070987846702337265, 0.026071127504110336, -0.06666237115859985, -0.13753549754619598, 0.20397314429283142, -0.03248872980475426, -0.23605512082576752, -0.07327748090028763, -0.20228266716003418, 0.21875318884849548, -0.10602664947509766, -0.024629801511764526, -0.1240701973438263, -0.1608380228281021, 0.09605575352907181, -0.011867129243910313, 0.06264347583055496, -0.16354212164878845, 0.1015612930059433, 0.014964493922889233, -0.054192692041397095, 0.1844416856765747, -0.08843791484832764, 0.18206511437892914, 0.019391346722841263, -0.03379160538315773, 0.11766750365495682, 0.13665631413459778, 0.015388120897114277, 0.2038893848657608, -0.03310742974281311, 0.0016493548173457384, 0.07982666790485382, 0.23400992155075073, -0.14512395858764648, -0.057402726262807846, 0.10150530934333801, 0.010063434951007366, 0.05893302708864212, -0.008477268740534782, -0.16710150241851807, -0.14271223545074463, -0.038852039724588394, 0.049866680055856705, -0.25069135427474976, 0.012354840524494648, 0.006442928221076727, -0.21163955330848694, -0.07004887610673904, 0.17324073612689972, -0.15125539898872375, 0.10996057093143463, 0.020222779363393784, 0.04184487834572792, -0.14864222705364227, -0.04607314616441727, 0.18424363434314728, 0.046407200396060944, 0.15379123389720917, 0.14828823506832123, -0.039850808680057526, 0.03850055858492851, -0.2721799910068512, 0.19857701659202576, -0.13789701461791992, 0.04919010400772095, -0.1453741192817688, 0.22524520754814148, 0.2178359031677246, 0.11920581012964249, -0.1131654754281044, 0.008069549687206745, 0.10178997367620468, 0.07683312892913818, 0.027350855991244316, -0.005720036569982767, 0.26661625504493713, 0.2430044561624527, 0.06996135413646698, -0.14241766929626465, 0.009593022987246513, 0.0693267211318016, -0.02101089432835579, -0.014072789810597897, -0.0752766951918602, -0.014585113152861595, -0.060620274394750595, -0.02876443974673748, 0.054988883435726166, -0.1967586725950241, 0.16229750216007233, 0.21555234491825104, 0.07180769741535187, -1.5799878344119908e-32, 0.0909615084528923, 0.017307503148913383, 0.1042231023311615, -0.03802882507443428, -0.17044135928153992, -0.05904883146286011, -0.06350049376487732, 0.19646255671977997, 0.04818497225642204, 0.20171476900577545, 0.08808761090040207, 0.1757238507270813, -0.09931283444166183, 0.13497640192508698, -0.1179090216755867, -0.0025008514057844877, 0.13859343528747559, -0.1535104513168335, -0.07678215950727463, 0.08044502884149551, -0.11141800880432129, 0.06512804329395294, -0.03870752081274986, 0.27466702461242676, 0.1306772381067276, -0.02818267233669758, 0.19445525109767914, 0.13538207113742828, 0.05924869328737259, 0.12337108701467514, -0.1645350456237793, 0.03286715969443321, -0.08639980107545853, -0.057770516723394394, -0.0928308442234993, -0.08813580125570297, 0.1098778173327446, -0.09094896912574768, -0.05827302485704422, -0.05485687404870987, 0.05183226242661476, -0.13183417916297913, 0.06796733289957047, 0.09823726862668991, 0.22135910391807556, -0.09805630892515182, 0.03859154134988785, -0.022267352789640427, 0.2979150712490082, -0.030097348615527153, 0.09691859781742096, 0.105189748108387, 0.16372640430927277, 0.026527585461735725, -0.10316403955221176, 0.07762017101049423, -0.009965251199901104, -0.10167679190635681, -0.027792032808065414, -0.11434556543827057, -0.04439824819564819, 0.16495496034622192, -0.224596306681633, -0.06856468319892883, 0.04390107840299606, 0.06984101235866547, -0.07000058889389038, 0.036181848496198654, 0.04138447344303131, -0.06557667255401611, 0.14100195467472076, -0.14105787873268127, -0.013063007034361362, -0.1841306984424591, 0.04504495486617088, 0.07847307622432709, 0.018696259707212448, 0.0468771867454052, -0.06987222284078598, 0.08848652243614197, 0.029310904443264008, -0.10164890438318253, -0.02607293240725994, -0.03362040966749191, -0.21979276835918427, 0.004958040546625853, 0.08904518932104111, -0.037313397973775864, -0.09797713160514832, 0.02497056871652603, -0.29510799050331116, -0.13613462448120117, -0.15962004661560059, 0.14544610679149628, 0.11094249784946442, -9.988187343878963e-08, -0.03313710540533066, 0.03517480194568634, 0.011314700357615948, 0.13764792680740356, 0.20826685428619385, 0.06977766007184982, 0.048300959169864655, -0.011402729898691177, 0.10547985136508942, 0.242740660905838, -0.11950314044952393, 0.18188156187534332, -0.026187432929873466, -0.12139236927032471, -0.1693180799484253, 0.19430002570152283, -0.09261833131313324, -0.05049057677388191, 0.1308353990316391, -0.24704581499099731, 0.06440924108028412, 0.0016242729034274817, 0.4124658703804016, -0.05102105438709259, -0.07391531020402908, -0.0718836635351181, -0.07684280723333359, -0.04136694595217705, -0.10610069334506989, -0.0741502046585083, -0.10734348744153976, 0.008543210104107857, 0.07608836889266968, -0.020249059423804283, 0.14658252894878387, 0.10221821814775467, 0.026074005290865898, -0.029308483004570007, 0.03479578718543053, 0.02179696038365364, -0.07389752566814423, 0.06120779365301132, 0.005635445471853018, 0.00394996115937829, -0.1319439560174942, -0.06670708954334259, -0.18445436656475067, -0.02658235840499401, 0.13780726492404938, -0.17328201234340668, -0.02321244403719902, -0.16557183861732483, -0.06900112330913544, -0.008201297372579575, -0.02291940711438656, 0.0956951230764389, -0.0702488124370575, -0.13497216999530792, -0.2086869776248932, -0.09532629698514938, -0.021031653508543968, -0.30996614694595337, -0.029361585155129433, 0.1745799332857132], "changes": {"1wk": -1.1397752440794102}}, {"text": "Collegium Pharmaceutical Unveils 2025 Financial Projections TipRanks Thu, Jan 9, 2025, 4:30 PM 1 min read In This Article: COLL https://www.tipranks.com/news/the-fly/healthequity-announces-year-end-hsa-sales-outlook The latest announcement is out from Collegium Pharmaceutical ( (COLL) ). Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Collegium Pharmaceutical announced its 2025 financial guidance, projecting product revenues between $735 and $750 million, with a focus on Jornay PM expected to exceed $135 million in net revenue. The company completed the integration of Ironshore Therapeutics and plans targeted investments in Jornay PM to drive growth, aiming for significant top- and bottom-line growth and long-term shareholder value. More about Collegium Pharmaceutical Collegium Pharmaceutical, Inc. is a biopharmaceutical company that focuses on responsible pain management medications and neuropsychiatry, with its lead product Jornay PM for ADHD. The company aims to expand its commercial portfolio and is headquartered in Stoughton, Massachusetts. YTD Price Performance: 1.78% Average Trading Volume: 431,079 Technical Sentiment Consensus Rating: Hold Current Market Cap: $923M For an in-depth examination of COLL stock, go to TipRanks\u2019 Stock Analysis page . Trending Articles Tencent Repurchases $193M Worth of Stock to Support its Share Price Don\u2019t Miss Out! Class Action Lawsuit Against Hasbro Inc. (NASDAQ:HAS) Microsoft Attracts Analysts\u2019 Buy Ratings Despite High AI Capex Plans View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-09T16:30:14", "sentiment": {"score": 0.06980568543076515, "confidence": 0.08398418873548508, "probabilities": {"positive": 0.08398418873548508, "negative": 0.014178503304719925, "neutral": 0.9018372893333435}}, "embedding": [-0.0691065713763237, -0.243841290473938, -0.13813696801662445, 0.049110282212495804, 0.002366259228438139, -0.030464347451925278, -0.01303018070757389, 0.33312514424324036, 0.08084307610988617, -0.03883838281035423, -0.10713405162096024, 0.14689670503139496, 0.03403951972723007, 0.022978199645876884, -0.14437758922576904, 0.01229139231145382, 0.12948568165302277, -0.06007050722837448, -0.10554292052984238, 0.041110809892416, -0.03510744497179985, -0.0773315280675888, 0.045678798109292984, -0.024902893230319023, -0.0005287809181027114, 0.12817887961864471, -0.04828309640288353, -0.018745796754956245, -0.21467970311641693, -0.11144984513521194, 0.06251120567321777, 0.12778712809085846, 0.09262798726558685, -0.09620699286460876, 0.005455012433230877, 0.0037537117023020983, -0.15483546257019043, 0.04494274780154228, 0.07182634621858597, 0.0004377824952825904, 0.019075388088822365, -0.04603013023734093, -0.09728382527828217, -0.006008545868098736, 0.02466890960931778, -0.2768479883670807, -0.08189605921506882, -0.009924663230776787, 0.06195171922445297, 0.17800159752368927, -0.26794755458831787, -0.14503271877765656, 0.055771354585886, 0.054999660700559616, -0.17733906209468842, 0.06453453749418259, -0.13565334677696228, -0.03025585412979126, 0.03672357648611069, 0.028651300817728043, 0.020046770572662354, -0.036117203533649445, 0.09884265065193176, -0.027056684717535973, 0.19936808943748474, 0.012733097188174725, -0.0005439150845631957, -0.062696672976017, -0.04751560837030411, -0.035472843796014786, 0.08530902117490768, -0.055077485740184784, 0.009824208915233612, 0.060254111886024475, -0.0721123144030571, 0.14458678662776947, 0.018215375021100044, 0.06008250266313553, 0.24101288616657257, -0.019114024937152863, 0.0901021882891655, 0.11376743018627167, -0.02954106591641903, 0.08249207586050034, 0.029027266427874565, -0.011808867566287518, 0.1463288962841034, 0.1539703607559204, 0.1150963306427002, 0.037081558257341385, 0.12475388497114182, 0.006686090026050806, -0.14356796443462372, -0.031354472041130066, -0.10026564449071884, 0.047815632075071335, -0.11546257883310318, -0.004617549479007721, -0.07929151505231857, -0.013786991126835346, 0.11894527822732925, -0.001288692350499332, -0.07273217290639877, -0.13154037296772003, -0.07201547920703888, -0.08559843897819519, 0.1600685566663742, -0.003014048095792532, 0.008437387645244598, -0.048558447510004044, -0.05941859632730484, 0.12625247240066528, -0.1070469319820404, -0.03424573689699173, -0.10345958918333054, 0.15809810161590576, -0.029367482289671898, 0.0366547591984272, 0.22012488543987274, -0.08500014990568161, 0.08247078955173492, 0.08432377874851227, 0.024846263229846954, -0.07787133008241653, 0.12093579769134521, 0.032172348350286484, -0.22541660070419312, 1.250711883342704e-32, -0.050993770360946655, 0.06068336218595505, 0.010851888917386532, -0.01190267875790596, -0.07402966916561127, -0.0044572800397872925, 0.09094128012657166, 0.08124612271785736, -0.20591600239276886, -0.0677110105752945, -0.2452687919139862, 0.10156463831663132, -0.03223438188433647, -0.037573568522930145, 0.012723797000944614, -0.0858493521809578, 0.07069040834903717, -0.007265125866979361, 0.024621982127428055, -0.16068953275680542, 0.12307654321193695, 0.012221720069646835, -0.058278534561395645, 0.09681613743305206, -0.10092703253030777, 0.06629729270935059, -0.13832435011863708, 0.02034999057650566, 0.11598005890846252, 0.0937991589307785, -0.02279314585030079, 0.010720288380980492, -0.01518455520272255, -0.05928153917193413, 0.03851889446377754, -0.040928393602371216, -0.18025845289230347, -0.14227581024169922, 0.060850854963064194, 0.012773162685334682, -0.05830841138958931, 0.1759454309940338, -0.07505407184362411, -0.06020329147577286, -0.007957547903060913, 0.060587216168642044, -0.1865430772304535, 0.0417381189763546, -0.010703406296670437, -0.10615403950214386, -0.13398633897304535, 0.03033246286213398, 0.09561807662248611, -0.027399612590670586, -0.039853714406490326, 0.024855298921465874, -0.06698741018772125, -0.014214779250323772, 0.12009771913290024, 0.16608700156211853, -0.027301300317049026, 0.10501045733690262, -0.11562193185091019, 0.030296698212623596, -0.14831562340259552, 0.2161986082792282, -0.023068737238645554, 0.06483584642410278, -0.033261045813560486, 0.11510537564754486, 0.10513212531805038, 0.07478021085262299, 0.0943070650100708, 0.10174953937530518, 0.09567965567111969, -0.09797921776771545, 0.057303279638290405, 0.047799792140722275, 0.03557410463690758, -0.03141186386346817, 0.09587671607732773, -0.1107671931385994, -0.10156350582838058, 0.07873184978961945, -0.015292114578187466, -0.07716434448957443, -0.004792475141584873, -0.02465704083442688, -0.1065794825553894, -0.03009621426463127, -0.03160081058740616, -0.0686199888586998, -0.06477377563714981, 0.15429319441318512, -0.05433228611946106, -9.80033737914733e-33, -0.10008298605680466, -0.024596184492111206, 0.10311738401651382, 0.007516998331993818, -0.06219718977808952, 0.05320115387439728, 0.039434608072042465, -0.07179056853055954, 0.08224182575941086, -0.006839853711426258, 0.02613324113190174, 0.03109942562878132, -0.09237221628427505, 0.025983180850744247, -0.06883317232131958, 0.14279405772686005, -0.051141414791345596, -0.17369277775287628, -0.05302346497774124, -0.0861145630478859, -0.002235088963061571, 0.18927450478076935, -0.06694739311933517, 0.19468143582344055, 0.06035151705145836, 0.08094702661037445, 0.07695762813091278, 0.02584296278655529, -0.01606983132660389, 0.1437893658876419, -0.02887248992919922, 0.07259132713079453, -0.19643867015838623, 0.009062438271939754, -0.12864255905151367, 0.025833316147327423, 0.005126438569277525, -0.2129504233598709, -0.004485867451876402, 0.03385283797979355, 0.08413919061422348, -0.0670958012342453, 0.02502363547682762, 0.018824897706508636, 0.12246992439031601, -0.05601353198289871, -0.0017496547661721706, -0.018505128100514412, 0.2250046283006668, 0.08763058483600616, 0.01612272672355175, 0.06749176234006882, 0.0268991831690073, 0.05834280699491501, -0.06696529686450958, 0.01272363867610693, 0.049302201718091965, -0.07566078752279282, -0.16943004727363586, -0.10186535120010376, 0.05645474046468735, 0.16997377574443817, -0.018550539389252663, 0.019960785284638405, 0.07059717178344727, 0.13314074277877808, 0.006203558295965195, 0.08338417112827301, -0.02874036505818367, -0.14469791948795319, 0.03958432748913765, -0.09096867591142654, 0.1586325764656067, -0.07189736515283585, 0.02191830612719059, 0.18634033203125, 0.026884211227297783, -0.07158250361680984, -0.117762990295887, 0.04937698692083359, 0.0396205335855484, -0.07327143847942352, 0.06057024747133255, -0.021729758009314537, -0.06248191371560097, 0.03643413260579109, 0.14566263556480408, 0.027919767424464226, -0.1164524182677269, 0.0198952779173851, -0.0896388441324234, -0.10774073004722595, -0.0902157723903656, 0.14390598237514496, 0.13426895439624786, -9.949814483434238e-08, -0.037751078605651855, -0.06842028349637985, 0.009249402210116386, 0.04150354489684105, 0.12282144278287888, -0.08323972672224045, 0.01656225696206093, 0.0730365514755249, 0.015194693580269814, 0.22848844528198242, 0.024439649656414986, 0.08110353350639343, -0.22710943222045898, 0.03489121049642563, -0.13015532493591309, 0.09522414952516556, -0.12372135370969772, 0.07654228061437607, 0.010412023402750492, -0.08792509883642197, 0.022241175174713135, 0.03770994395017624, 0.17065809667110443, -0.059902433305978775, 0.043509818613529205, -0.1158209964632988, -0.05127556249499321, -0.03237873315811157, 0.0446811318397522, -0.04396779090166092, -0.0016022233758121729, -0.015385785140097141, 0.1783290058374405, 0.011093301698565483, -0.025198621675372124, -0.04666588827967644, -0.0015459569403901696, 0.0725557804107666, 0.0009754305938258767, 0.11974309384822845, -0.07941669970750809, 0.00948754046112299, 0.0002971458015963435, 0.019504105672240257, -0.043959926813840866, -0.07837574183940887, -0.17498667538166046, 0.05646948516368866, 0.14507515728473663, -0.103858582675457, -0.004249232821166515, -0.0336737334728241, 0.015454781241714954, 0.015099077485501766, -0.019152238965034485, 0.10879435390233994, -0.0692228153347969, -0.015168688260018826, -0.18566778302192688, -0.06730030477046967, 0.04013008996844292, -0.24603112041950226, 0.058602068573236465, 0.1189756989479065], "changes": {"1wk": 0.15192718715396342}}, {"text": "Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter PR Newswire Fri, Jan 10, 2025, 4:00 PM 9 min read The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter offers electrophysiologists the ability to switch between radiofrequency and pulsed field energy in a single, fully integrated catheter CE Mark supported by the SmartfIRE study on the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter for the treatment of paroxysmal atrial fibrillation (AFib) Additional milestones announced include complete enrollment of the SmartPulse and PulseSmart trials IRVINE, Calif. , Jan. 10, 2025 /PRNewswire/ -- Johnson & Johnson\u00a0MedTech, a global leader in cardiac arrhythmia treatment, today announced European CE mark approval of the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter for the treatment of cardiac arrhythmias. The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter is an irrigated, contact-force sensing catheter powered by the TRUPULSE\u2122 Generator, and is fully integrated with the CARTO\u2122 3 System for electro-anatomical mapping and for tag indexing. 1 The company expects\u00a0TRUPULSE\u2122 Generator hardware compatibility in the first half of 2025. When fully approved, the platform will provide electrophysiologists with the ability to switch between radiofrequency (RF) and pulsed field (PF) energy in the same catheter they know and trust. The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter is not currently approved in the United States . The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter is designed on the same platform as the radiofrequency THERMOCOOL SMARTTOUCH\u2122 SF Catheter \u2013 the most commonly used catheter in the world today, with many years of physician experience. (PRNewsfoto/Johnson & Johnson MedTech) \"As the number of people with AFib grows around the world, physicians are looking for integrated and flexible tools to help deliver safe, effective and efficient cardiac ablation procedures,\"\u00a0said\u00a0Tom De Potter, M.D.,\u00a0Head of Electrophysiology and Associate Director of the Heart Center, OLV Hospital , Aalst, Belgium . i \"Both\u00a0PF and RF energy have important advantages in clinical practice. With the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter, having the ability to easily switch between RF and PF energy provides the flexibility to customize treatment depending on the patient anatomy and clinical need, enabling electrophysiologists to perform more targeted ablation procedures which could lead to improved outcomes for patients.\" The safety and efficacy of the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter was investigated in the SmartfIRE clinical trial. 2 Early results from the study, published in April 2024 , showed that the use of the catheter led to a 100% acute success rate, with first-pass isolation achieved in 96.8% of veins. 3 * Story Continues \"Based on our collaboration with electrophysiologists around the world, we know that each AFib procedure is different; having both RF and PF energy through one device will allow physicians to personalize each procedure based on patient anatomy and clinical need and offer a point-by-point workflow that many of our customers prefer,\" said Jasmina Brooks , President, Electrophysiology, Johnson & Johnson MedTech. \"The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter offers the benefit of both energy modes in one familiar device. We are pleased to bring forward this innovation to enable electrophysiologists to deliver safe and effective procedures for patients in Europe impacted by AFib.\" Additional Studies Underway In addition to receiving European CE Mark approval, the company is making strides to bring the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter to other regions of the world. The company has completed enrollment in the SmartPulse clinical trial \u2013 a prospective, single arm, multi-center clinical study of 250 patients with paroxysmal atrial fibrillation (PAF) across 27 sites in the United States to evaluate the safety and effectiveness of the Dual Energy\u00a0THERMOCOOL SMARTTOUCH\u2122 SF Catheter. The\u00a0PulseSmart clinical trial, evaluating the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter in Australia and Canada , has also completed enrollment. This trial enrolled 136 patients with drug-refractory PAF across 7 sites. \"The ability to deliver both PF and RF energy via the same catheter simplifies the workflow for ablation procedures and enables personalized treatment,\" said Dr. Dhanunjaya (DJ) Lakkireddy, Executive Medical Director, Kansas City Heart Rhythm Institute iii , who took part in the\u00a0SmartPulse clinical trial. 2 \"In addition, the integration of the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF\u00a0Catheter with the CARTO\u2122 3 System can enable real-time catheter visualization and feedback on contact force measurements and tag indexes, which are important factors for durable lesion formation.\" \"The SmartPulse and PulseSmart studies are part of a broad set of PFA clinical trials and diverse research initiatives that Johnson & Johnson MedTech is undertaking to generate the evidence necessary to guide informed treatment decisions, optimize clinical use, and ultimately enhance AFib treatment outcomes,\" said Jennifer Currin , Ph.D., Vice President, Scientific Affairs at Johnson & Johnson MedTech. Catheter ablation is a minimally invasive procedure performed by an electrophysiologist to treat heart rhythm disorders, including AFib, by interrupting irregular electrical pathways in the heart. 4 Catheter ablation can be more than four times more effective than antiarrhythmic drugs alone in preventing recurrent arrhythmia in AFib patients. ii ,5 In addition to the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter, Johnson & Johnson MedTech is committed to offering a portfolio of products designed to work seamlessly together for optimal efficiency and compatibility in the treatment of cardiac arrhythmias. About the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Platform consists of the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter ii \u2013 an irrigated, contact-force sensing catheter \u2013 and the TRUPULSE\u2122 Generator, providing both RF and PF energy to the catheter through the toggling of the two energy sources on the generator monitor. 2 The catheter and the generator are fully integrated with the world's leading CARTO\u2122 3 System, enabling live 3D mapping and advanced visualization during ablation procedures. ii The Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter is the first dual energy pulsed field ablation (PFA) / radiofrequency (RF) ablation catheter integrated with a PF and RF tag index. About the SmartfIRE Study SmartfIRE is an open-label interventional study evaluating the safety and efficacy of the investigational Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter with the TRUPULSE\u2122 Generator, in the treatment of paroxysmal atrial fibrillation. The study enrolled 149 adult patients in Europe with drug refractory paroxysmal AFib, identified as candidates for catheter ablation, who received (PF) or (RF) catheter ablation using the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter and TRUPULSE\u2122 generator during their cardiac ablation procedure. The study includes patients experiencing recurrent symptomatic atrial fibrillation following at least one antiarrhythmic drug (AAD; class I to IV), or patients who can either not tolerate AAD or for whom AAD is contraindicated. Cardiovascular Solutions from Johnson & Johnson MedTech Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation we are addressing conditions with significant unmet needs such as heart failure, coronary artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circular restoration and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke. For more, visit biosensewebster.com and connect on LinkedIn and X, formerly Twitter . About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com . Biosense Webster, Inc. is a Johnson & Johnson MedTech company. Cautions Concerning Forward-Looking Statements This press release contains \"forward-looking statements\" as defined in the Private Securities Litigation Reform Act of 1995 regarding the Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of regulatory approvals; uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of healthcare products and services; and trends toward healthcare cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 , including in the sections captioned \"Cautionary Note Regarding Forward-Looking Statements\" and \"Item 1A. Risk Factors,\" and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at sec.gov , jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments. \u00a9 Johnson & Johnson and its affiliates 2025. All rights reserved. M_US_BWI_THER_394529 1 The CARTO VISITAG\u2122 Module provides access to data collected during the application of energy. The Tag Index values should not be used to guide energy delivery. * n=137 2 ClinicalTrials.gov. Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH\u2122 SF Catheter with the TRUPULSE\u2122 Generator for treatment of Paroxysmal Atrial Fibrillation (PAF) (SmartfIRE). \" https://clinicaltrials.gov/ct2/show/NCT05752487 . 3 Mattias Duytschaever , et al. Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results, EP Europace, Volume 26, Issue 5, May 2024 , euae088, https://doi.org/10.1093/europace/euae088 4 British Heart Foundation. Catheter Ablation. Available at: https://www.bhf.org.uk . Last accessed: January 2024 . 5 Joglar, J, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024 Jan, 83 (1) 109\u2013279. i OLV Hospital entered into a clinical trial agreement with Johnson & Johnson Medical NV/SA for its participation in the SmartfIRE Study. Dr. Tom De Potter serves as a study investigator and was not compensated for his contributions to this announcement. ii Results reported after 9 months for patients with paroxysmal AFib who had failed 1 antiarrhythmic medication in randomized trial. iii Kansas City Heart Rhythm Institute entered into a clinical trial agreement with Biosense Webster, Inc. for its participation in the SmartPulse study. Dr. Dhanunjaya (DJ) Lakkireddy serves as a study investigator and was not compensated for his contributions to this announcement. Media contact: Diane Pressman Dpressm1@its.jnj.com Anna Loring Aloring1@its.jnj.com I nvestor Relations: Tracy Menkowski investor-relations@its.jnj.com Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-medtech-announces-ce-mark-approval-for-dual-energy-thermocool-smarttouch-sf-catheter-302347949.html SOURCE Johnson & Johnson MedTech View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-10T16:00:00", "sentiment": {"score": 0.14357363525778055, "confidence": 0.15214166045188904, "probabilities": {"positive": 0.15214166045188904, "negative": 0.008568025194108486, "neutral": 0.8392903208732605}}, "embedding": [-0.14596861600875854, -0.08788220584392548, -0.10130985826253891, 0.0535140298306942, -0.033845558762550354, -0.13108840584754944, -0.026295188814401627, 0.18697428703308105, 0.023554809391498566, 0.008673529140651226, 0.009632683359086514, -0.07542787492275238, -0.013790616765618324, 0.11949649453163147, 0.0006238138303160667, -0.028288759291172028, 0.05028802901506424, -0.08164986968040466, 0.04540146887302399, 0.10625049471855164, 0.06905786693096161, 0.008298790082335472, 0.0238848514854908, -0.058333203196525574, -0.10159283876419067, -0.046396877616643906, -0.13793990015983582, -0.004613771568983793, -0.18075427412986755, 0.0752052590250969, -0.05047701299190521, 0.06792417913675308, -0.09895098209381104, -0.009565990418195724, -0.00013664527796208858, 0.08137527853250504, 0.024472035467624664, 0.1446012705564499, -0.0800561010837555, -0.011074451729655266, -0.08629754930734634, -0.16583645343780518, -0.022899411618709564, 0.008099230006337166, 0.010558786801993847, -0.055813565850257874, -0.069463349878788, -0.17273232340812683, -0.034334879368543625, 0.08791975677013397, -0.049252770841121674, -0.004647405818104744, 0.15323545038700104, 0.16866552829742432, -0.053126655519008636, 0.00942069198936224, -0.1139649748802185, -0.0493544265627861, -0.061363767832517624, -0.07626179605722427, -0.13056278228759766, -0.028002839535474777, -0.0382402278482914, -0.020634720101952553, 0.0353933647274971, -0.02437051758170128, 0.10214920341968536, -0.018294228240847588, 0.11689694970846176, -0.09567058086395264, -0.04549537971615791, -0.08975160866975784, 0.2532021999359131, 0.007052065804600716, 0.07316926121711731, 0.04222042113542557, 0.1111987978219986, 0.05180808901786804, 0.07854051142930984, -0.07214491069316864, -0.04332342743873596, -0.06597211211919785, -0.08934424817562103, -0.11352987587451935, -0.01279580406844616, 0.16255249083042145, 0.01353791356086731, 0.05124891921877861, 0.03498227521777153, 0.0164335910230875, 0.13648194074630737, 0.050229668617248535, -0.039418645203113556, 0.003150222823023796, -0.004182619974017143, -0.1415078192949295, 0.00856234971433878, 0.045627593994140625, -0.011045025661587715, -0.07019424438476562, 0.005121948197484016, -0.0038816710002720356, -0.2011660635471344, 0.04851827025413513, 0.09426958858966827, -0.1868395358324051, -0.049897581338882446, -0.09553097188472748, 0.13318464159965515, -0.10508577525615692, 0.16061130166053772, 0.13349488377571106, -0.03381645679473877, -0.07428748905658722, -0.051495522260665894, 0.16849292814731598, -0.10658089816570282, 0.011821633204817772, 0.285915344953537, 0.07071052491664886, -0.11991856247186661, -0.094013512134552, -0.10757966339588165, -0.05209910497069359, 0.050468288362026215, 0.004716780968010426, 0.0657791793346405, 1.8600246781140335e-32, -0.01339772343635559, 0.10347260534763336, 0.10700762271881104, -0.16124697029590607, 0.004762687720358372, -0.024663621559739113, -0.11959852278232574, 0.06620878726243973, -0.021390775218605995, -0.03292779624462128, 0.02603134699165821, 0.15975889563560486, 0.09412321448326111, 0.02384275756776333, -0.08804645389318466, -0.19167134165763855, -0.16476555168628693, 0.07937777042388916, -0.0357658714056015, -0.052315324544906616, 0.1346818506717682, -0.02614191174507141, 0.046383701264858246, 0.152225524187088, 0.0975474864244461, 0.2835000157356262, -0.10474853217601776, 0.1498679518699646, 0.0272282175719738, 0.10207796096801758, -0.13185827434062958, 0.008888117969036102, -0.0469500757753849, -0.043570566922426224, -0.10816499590873718, -0.06619876623153687, -0.07280345261096954, -0.005967696197330952, -0.044224515557289124, 0.06933198869228363, 0.1379762887954712, 0.11602701246738434, 0.12518706917762756, 0.0038643949665129185, 0.03409904986619949, -0.15601184964179993, -0.013181081041693687, 0.04961560666561127, 0.047377265989780426, -0.03255954757332802, -0.0766420066356659, -0.1266363561153412, 0.014469945803284645, -0.08852922916412354, 0.10343088209629059, 0.018348947167396545, -0.05828367918729782, 0.07865242660045624, 0.2254444658756256, 0.1289524883031845, 0.0013095205649733543, 0.07914647459983826, -0.018213260918855667, -0.03132747858762741, 0.007532847113907337, 0.10432074964046478, 0.05654245987534523, -0.14001469314098358, -0.017424045130610466, 0.06880737841129303, -0.10801500827074051, 0.14809554815292358, 0.08739534020423889, -0.11983440816402435, 0.15858101844787598, 0.058512620627880096, -0.03062712959945202, 0.15405085682868958, -0.09320001304149628, -0.23849810659885406, -0.1254221796989441, 0.06225576996803284, 0.05082489922642708, 0.09568269550800323, 0.06598419696092606, -0.09974631667137146, -0.03667881339788437, 0.07821941375732422, -0.24903155863285065, -0.02557053603231907, 0.06410303711891174, 0.10115586966276169, 0.026386719197034836, -0.04447076469659805, -0.03918785601854324, -1.5363461372697748e-32, 0.019950123503804207, -0.06050083041191101, -0.018122324720025063, -0.007480747997760773, 0.030796760693192482, 0.04314955323934555, 0.1673213690519333, -0.13196027278900146, 0.012759458273649216, -0.09604939073324203, 0.09602892398834229, 0.023587601259350777, -0.08471570909023285, -0.018261469900608063, -0.0929105132818222, 0.14504820108413696, -0.11884626746177673, -0.061726003885269165, -0.031664542853832245, 0.09304167330265045, 0.17403236031532288, 0.1945340633392334, -0.04767712205648422, 0.14636313915252686, -0.01192215085029602, -0.01937340945005417, 0.019801978021860123, -0.06588363647460938, 0.03571203351020813, -0.14366939663887024, -0.09743976593017578, -0.03095756657421589, -0.12244661152362823, 0.025658251717686653, -0.05003649741411209, -0.020637590438127518, 0.07446767389774323, 0.045689478516578674, 0.064377561211586, 0.025083251297473907, 0.05159761756658554, 0.14763548970222473, -0.13386836647987366, 0.07393481582403183, -0.15728139877319336, 0.07839654386043549, -0.045964132994413376, -0.19038569927215576, -0.03345607966184616, 0.10429143905639648, -0.057558029890060425, -0.05985003709793091, -0.15320535004138947, 0.0584786981344223, -0.06788118183612823, -0.007997939363121986, -0.036803245544433594, -0.01826879009604454, -0.242909237742424, -0.012502100318670273, 0.09131844341754913, -0.0009744081180542707, 0.15835875272750854, 0.047987617552280426, 0.2064240574836731, 0.20667769014835358, 0.07638593018054962, 0.058524493128061295, 0.09039296209812164, -0.02286941185593605, 0.10411114990711212, 0.0998578891158104, 0.021029144525527954, -0.15525969862937927, 0.04652980715036392, 0.07267903536558151, 0.16609826683998108, -0.17101767659187317, -0.09248015284538269, -0.060985393822193146, 0.03408478945493698, -0.00018622074276208878, -0.04724845662713051, 0.05141831189393997, 0.07995224744081497, 0.060382504016160965, 0.11411143839359283, -0.023234982043504715, -0.035285867750644684, -0.048725735396146774, 0.016514860093593597, -0.005619700998067856, -0.0031967288814485073, 0.11238857358694077, 0.04999321326613426, -1.0028637120740314e-07, -0.052933674305677414, 0.02700667269527912, -0.13490080833435059, -0.001123230904340744, -0.029741765931248665, -0.0784502625465393, -0.07518725097179413, -0.009790526703000069, -0.15712766349315643, -0.0380580872297287, 0.045671287924051285, 0.07851444184780121, 0.11832448840141296, -0.034503836184740067, 0.16169047355651855, -0.09245498478412628, -0.008942090906202793, 0.03203718364238739, -0.10036392509937286, -0.012962264940142632, -0.00404001772403717, -0.060932740569114685, -0.06542977690696716, -0.08723534643650055, 0.13897767663002014, 0.16700901091098785, -0.028638143092393875, -0.04511155188083649, 0.09524135291576385, -0.07953527569770813, -0.053235478699207306, -0.08888769149780273, -0.022852763533592224, 0.11006705462932587, -0.004775363951921463, -0.06830011308193207, -0.03344667702913284, 0.010638304054737091, -0.0330992266535759, 0.23967856168746948, 0.13576143980026245, -0.09566687047481537, -0.21747343242168427, 0.03767026215791702, -0.11001138389110565, -0.12795782089233398, -0.09493106603622437, -0.08901073038578033, 0.04678463935852051, 0.2444983422756195, 0.027070626616477966, -0.016613999381661415, 0.026063192635774612, -0.13389916718006134, -0.07493104785680771, 0.034240707755088806, -0.04138665273785591, -0.05505858361721039, -0.03141167387366295, 0.07758474349975586, 0.18427705764770508, -0.07842393219470978, 0.012059823609888554, 0.06409697979688644], "changes": {"1wk": 1.6712222412963527}}, {"text": "Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA\u00ae (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of \u226540% Business Wire Fri, Jan 10, 2025, 5:30 PM 11 min read KERENDIA \u00ae (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular endpoint in a Phase III study investigating patients with HF with mildly reduced or preserved ejection fraction (LVEF \u226540%) 1 Regulatory submission is based on positive data from the Phase III FINEARTS-HF study recently presented at European Society of Cardiology (ESC) Congress 2024, and simultaneously published in the New England Journal of Medicine 1 KERENDIA is currently approved to reduce the risk of cardiovascular death, hospitalization for HF, non-fatal myocardial infarction (MI), sustained eGFR decline, and end-stage kidney disease in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) 2 WHIPPANY, N.J., January 10, 2025 --( BUSINESS WIRE )--Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for KERENDIA \u00ae (finerenone) for the treatment of patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of \u226540%. The submission is based on positive results from the Phase III FINEARTS-HF trial that showed finerenone achieved a statistically significant reduction of the composite of cardiovascular death and total (first and recurrent) HF events, defined as either an unplanned hospitalization for HF or an urgent HF visit, by 16% in patients with HF and a LVEF of \u226540% compared to placebo in addition to a patients\u2019 prescribed treatment regimen. Serious adverse events were comparable between treatment groups, occurring in 38.7% (1,157/2,993) of the finerenone group and 40.5% (1,213/2,993) of the placebo group. 1 The results were presented at the 2024 European Society of Cardiology (ESC) Congress and published in The New England Journal of Medicine . KERENDIA is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular endpoint in a Phase III study investigating patients with HF with mildly reduced or preserved ejection fraction (LVEF \u226540%). KERENDIA already has established cardiovascular benefit (reduction in hospitalization for HF, CV death and non-fatal MI) in adults with chronic kidney disease (CKD) in type 2 diabetes (T2D); the data from the FINEARTS-HF trial provide positive results in a different patient population not limited to CKD in T2D\u2014 patients diagnosed with HF (LVEF \u226540%). 1 \"More than half of the approximately 6.7 million adults in the U.S. diagnosed with heart failure have an LVEF \u226540%, but there are limited guideline-directed treatment options available for these patients,\" said Alanna Morris, M.D., MSc, Senior Medical Director of U.S. Medical Affairs, Bayer. 3,4 \"If approved, Kerendia could serve as a new pillar of therapy in this disease and improve cardiovascular outcomes for patients with high unmet medical need.\" Story Continues HF is a complex clinical syndrome with symptoms and signs that result from any structural or functional impairment of ventricular filling or ejection of blood. 5 Approximately 6.7 million adults in the U.S. live with HF, of which about 55% have a LVEF \u226540%. 3 Despite the high prevalence, there are limited guideline-directed medical treatment options for patients with HF with LVEF \u226540%. 4 This patient group is often balancing multiple comorbidities, such as obesity, diabetes, hypertension and CKD. 5 About FINEARTS-HF 6 The FINEARTS-HF trial, a randomized, double-blind, placebo-controlled, multicenter, event-driven Phase III trial investigated the efficacy and safety of finerenone for the reduction of risk of cardiovascular death and heart failure (HF) events in patients with a diagnosis of symptomatic heart failure (New York Heart Association class II-IV) with a left ventricular ejection fraction (LVEF) of \u226540%, measured by local imaging measurement within the last 12 months as well as receiving diuretic treatment for at least 30 days prior to randomization. The primary endpoint of FINEARTS-HF was the composite of cardiovascular death and total (first and recurrent) HF events, defined as hospitalizations for HF or urgent HF visits. Approximately 6,000 patients were randomized to receive finerenone or placebo once daily for up to 42 months. Results from FINEARTS-HF, which were published in The New England Journal of Medicine and presented at the European Society of Cardiology (ESC) Congress earlier this year, showed the trial met its primary endpoint, achieving a 16% (rate ratio, 0.84; 95% confidence interval [CI], 0.74 to 0.95; P = 0.007) relative risk reduction of the composite primary endpoint of cardiovascular death and total (first and recurrent) heart failure (HF) events (defined as hospitalizations for HF or urgent HF visits) compared to placebo in addition to a patients\u2019 prescribed treatment regimen. 1 In the FINEARTS-HF trial, no new safety signals were identified compared with those seen in previous studies with the compound. 1 Serious adverse events were comparable between treatment groups, occurring in 38.7% (1,157/2,993) of the finerenone group and 40.5% (1,213/2,993) of the placebo group. Discontinuation of the trial drug for reasons other than death was similar between groups, with 20.4% (611/2,993) in the finerenone group and 20.6% (616/2,993) in the placebo group 1 Increases in creatinine and potassium levels were more frequent in patients receiving finerenone compared to placebo, with investigator-reported hyperkalemia in 9.7% (289/2,993) of finerenone-treated patients versus 4.2% (125/2,993) in the placebo group. Serum potassium levels >6 mmol/L were observed in 3% (n=86) of the finerenone group compared to 1.4% (41/2,993) in the placebo group. Hyperkalemia was more common with finerenone; it led to hospitalization in 0.5% [16/2,993] in the finerenone group versus 0.2% [6/2,993] in the placebo group, and no cases resulted in death. 1 With overall more than 15,000 patients, the MOONRAKER clinical trial program with finerenone, including FINEARTS-HF, is one of the largest HF trial programs to date, and aims to establish a comprehensive body of evidence for finerenone across a broad spectrum of patients and clinical settings. 7 About KERENDIA \u00ae (finerenone) 2 KERENDIA is a non-steroidal mineralocorticoid receptor antagonist (nsMRA) and was approved by the U.S. Food and Drug Administration (FDA) in July 2021 to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction (MI), and hospitalization for HF in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D). In adults with CKD associated with T2D, KERENDIA has been recommended to improve cardiovascular outcomes and reduce the risk of CKD progression by the American Diabetes Association (ADA) 8 and reduce CV and kidney failure risk on top of standard of care by the European Society of Cardiology (ESC). 9 IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS: Concomitant use with strong CYP3A4 inhibitors Patients with adrenal insufficiency WARNINGS AND PRECAUTIONS: Hyperkalemia: KERENDIA can cause hyperkalemia. The risk for developing hyperkalemia increases with decreasing kidney function and is greater in patients with higher baseline potassium levels or other risk factors for hyperkalemia. Measure serum potassium and eGFR in all patients before initiation of treatment with KERENDIA and dose accordingly. Do not initiate KERENDIA if serum potassium is >5.0 mEq/L. Measure serum potassium periodically during treatment with KERENDIA and adjust dose accordingly. More frequent monitoring may be necessary for patients at risk for hyperkalemia, including those on concomitant medications that impair potassium excretion or increase serum potassium. MOST COMMON ADVERSE REACTIONS: From the pooled data of 2 placebo-controlled studies, the adverse reactions reported in \u22651% of patients on KERENDIA and more frequently than placebo were hyperkalemia (14% versus 6.9%), hypotension (4.6% versus 3.9%), and hyponatremia (1.3% versus 0.7%). DRUG INTERACTIONS: Strong CYP3A4 Inhibitors: Concomitant use of KERENDIA with strong CYP3A4 inhibitors is contraindicated. Avoid concomitant intake of grapefruit or grapefruit juice. Moderate and Weak CYP3A4 Inhibitors: Monitor serum potassium during drug initiation or dosage adjustment of either KERENDIA or the moderate or weak CYP3A4 inhibitor and adjust KERENDIA dosage as appropriate. Strong and Moderate CYP3A4 Inducers: Avoid concomitant use of KERENDIA with strong or moderate CYP3A4 inducers. USE IN SPECIFIC POPULATIONS: Lactation: Avoid breastfeeding during treatment with KERENDIA and for 1 day after treatment. Hepatic Impairment: Avoid use of KERENDIA in patients with severe hepatic impairment (Child Pugh C) and consider additional serum potassium monitoring with moderate hepatic impairment (Child Pugh B). Please click here for full Prescribing Information for KERENDIA. About Bayer\u2019s Commitment in Cardiovascular and Kidney Diseases Bayer upholds a long-standing commitment to delivering science for a better life by advancing research and treatment options. Bayer\u2019s cardiorenal franchise, which began with the discovery and development of a number of vital therapies, now includes several products and compounds in various stages of preclinical and clinical development with the potential to impact the way that CV and kidney diseases are treated. Bayer is investigating potential treatment approaches for areas of high unmet medical need. Currently, Bayer is investigating nine CVR-related projects in different stages of development, including heart failure (HF) and non-diabetic chronic kidney disease (CKD). 10 About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, \"Health for all, Hunger for none,\" the company\u2019s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed approximately 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com . Find more information at https://pharma.bayer.com/ Follow us on Facebook: http://www.facebook.com/bayer Follow us on X: @BayerPharma Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer\u2019s public reports, which are available on the Bayer website at www.bayer.com . The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. References Solomon S, et al. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2407107 . Accessed November 20, 2024. Bayer Pharmaceuticals. Kerendia (finerenone) [package insert]. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215341s000lbl.pdf . Accessed November 20, 2024. Bozkurt A, et al. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023; Oct;29(10):1412-1451. doi: 10.1016/j.cardfail.2023.07.006. Epub 2023 Sep 26. PMID: 37797885; PMCID: PMC10864030. Desai N, et al. Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment landscape. Heart Fail Rev. 2024;29(3):631-662. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11035416/. Accessed November 20, 2024. Heidenreich P, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023. https://pubmed.ncbi.nlm.nih.gov/35379503 . Accessed November 20, 2024 Trial to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% (FINEARTS-HF). Clinical trial registration No. NCT04435626. https://clinicaltrials.gov/study/NCT04435626 . Accessed November 20, 2024. Data on file. American Diabetes Association (Section 10: Cardiovascular disease and risk management: standards of care in diabetes\u20142024.). Diabetes Care. 2024;47(Suppl. 1):S179-S218. doi:10.2337/dc24-S010. Marx N, et al. ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J . 2023;44(39):4043-4140. doi:10.1093/eurheartj/ehad192 Bayer Pharmaceuticals. Development Pipeline. U.S. https://www.bayer.com/en/pharma/development-pipeline. Accessed November 10, 2024. COR-KER-US-0100-1 View source version on businesswire.com: https://www.businesswire.com/news/home/20250109213827/en/ Contacts Media Contact : Elaine Col\u00f3n Bayer Media Relations Elaine.colon@bayer.com +1-732-236-1587 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "COLL", "date": "2025-01-10T17:30:00", "sentiment": {"score": 0.4405786246061325, "confidence": 0.49431297183036804, "probabilities": {"positive": 0.49431297183036804, "negative": 0.053734347224235535, "neutral": 0.45195257663726807}}, "embedding": [0.01932905800640583, -0.08722853660583496, 0.020605092868208885, -0.11680711805820465, 0.04586751386523247, -0.05011642351746559, -0.2084890604019165, 0.21164411306381226, 0.0437382310628891, 0.014359887689352036, -0.04506983608007431, -0.048566918820142746, -0.04295775294303894, 0.02830713428556919, -0.06720037013292313, -0.0922938883304596, 0.08203946053981781, 0.11818073689937592, -0.1579299122095108, 0.13739150762557983, 0.024662578478455544, -0.046915411949157715, 0.02789944037795067, 0.0894956961274147, -0.05448950082063675, 0.038903623819351196, -0.22970053553581238, -0.0633208304643631, -0.06211279332637787, -0.004103195853531361, 0.013654452748596668, 0.12296219170093536, 0.005078177899122238, -0.013141151517629623, -0.09288004040718079, -0.05316569656133652, -0.1169549971818924, -0.05098079890012741, -0.2838749587535858, 0.022269530221819878, 0.029743753373622894, -0.1309714913368225, -0.22298651933670044, 0.06951328366994858, 0.08435121178627014, -0.18609873950481415, -0.05125683546066284, 0.09593576192855835, -0.04428495839238167, 0.18496708571910858, -0.06751660257577896, 0.035469815135002136, 0.011279290542006493, 0.06814755499362946, -0.08516578376293182, -0.0006583542563021183, -0.11809240281581879, -0.07794724404811859, 0.06439483165740967, 0.05443446338176727, -0.07090684771537781, -0.018800033256411552, 0.0067069921642541885, -0.073967844247818, 0.08738052845001221, -0.04783827066421509, -0.05182405933737755, -0.12404212355613708, -0.017614640295505524, 0.00011370610445737839, 0.12956088781356812, -0.22896549105644226, 0.02770872972905636, -0.021178264170885086, 0.02864462323486805, 0.15406890213489532, 0.03184424340724945, 0.008860601112246513, -0.058623671531677246, -0.0580739863216877, 0.13392838835716248, 0.11320295929908752, 0.018104301765561104, -0.08308416604995728, 0.12797963619232178, 0.03183795139193535, -0.05157829448580742, 0.12719203531742096, 0.015284067019820213, 0.010912362486124039, 0.18525904417037964, 0.06814959645271301, 0.0012026652693748474, 0.0515640452504158, 0.0465453676879406, -0.07757581770420074, -0.007543343119323254, 0.056946419179439545, -0.02934173308312893, 0.022572729736566544, 0.06882057338953018, -0.016956552863121033, -0.18210569024085999, -0.07281793653964996, -0.0009115654975175858, -0.0909104198217392, 0.09643897414207458, 0.03358083963394165, 0.05233575776219368, 0.06957843899726868, 0.00212183129042387, 0.035741742700338364, -0.01844235137104988, 0.033505141735076904, 0.05095824599266052, 0.1961650252342224, 0.02519659511744976, 0.007673939689993858, 0.17902691662311554, 0.033277131617069244, 0.019495580345392227, -0.06081142649054527, 0.014309472404420376, -0.04587762430310249, 0.03494593873620033, 0.17327731847763062, 0.08004063367843628, 1.088787536516934e-32, 0.1339043378829956, -0.004075259435921907, 0.0760113000869751, 0.01738889142870903, 0.06770078092813492, 0.004031934775412083, -0.09725780785083771, 0.07371121644973755, -0.026714591309428215, -0.2213047742843628, -0.14189115166664124, 0.08954621851444244, -0.030393380671739578, 0.09285475313663483, -0.14948701858520508, -0.09244643151760101, -0.04377686232328415, 0.014595048502087593, 0.1444639414548874, -0.04437204822897911, 0.026213359087705612, -0.08619977533817291, -0.0988885685801506, 0.05532083660364151, -0.11078450828790665, 0.033169616013765335, -0.08671752363443375, 0.09254226088523865, -0.04823799058794975, 0.016274750232696533, -0.10133858025074005, -0.1005120575428009, 0.08912306278944016, -0.12136949598789215, -0.1805393099784851, -0.06928986310958862, -0.11823853105306625, 0.04181629419326782, -0.05809086561203003, 0.014631470665335655, -0.015919681638479233, 0.10260076820850372, -0.01135472021996975, -0.016167698428034782, 0.16519969701766968, -0.17338503897190094, -0.012822809629142284, -0.02545439638197422, -0.06701391935348511, 0.021881358698010445, -0.012259227223694324, -0.07684613764286041, 0.1004343330860138, -0.0022571906447410583, -0.06669429689645767, 0.15138593316078186, -0.06350946426391602, -0.011500459164381027, 0.08188378065824509, 0.02524329349398613, -0.11188237369060516, 0.20916715264320374, 0.05490327626466751, 0.04982459545135498, -0.015258342027664185, 0.06082979962229729, -0.13520826399326324, -0.0615633949637413, -0.15987366437911987, -0.06711208820343018, -0.003698664717376232, 0.027206014841794968, 0.16329902410507202, 0.01226799562573433, 0.09190227091312408, -0.024807821959257126, 0.03283749893307686, 0.1523410975933075, -0.05500701814889908, -0.1745135337114334, -0.09456095099449158, 0.06000350043177605, -0.06386996805667877, 0.13163772225379944, -0.029323836788535118, 0.05191363766789436, 0.020376794040203094, -0.012261632829904556, -0.05940445885062218, -0.03326769545674324, -0.033308908343315125, -0.08559779822826385, -0.043286699801683426, 0.01908509060740471, 0.04378340765833855, -1.1348093158459773e-32, 0.0038160625845193863, -0.05072987824678421, 0.007756771054118872, 0.03284482657909393, 0.028194818645715714, 0.08691481500864029, 0.13408160209655762, -0.16684304177761078, 0.25059783458709717, -0.09669709950685501, 0.16589650511741638, -0.011864064261317253, 0.058938946574926376, -0.10697020590305328, -0.04037834703922272, 0.08668915182352066, -0.10823933780193329, -0.041039373725652695, -0.11370785534381866, 0.14025206863880157, 0.09671053290367126, -0.0309671051800251, -0.052126847207546234, 0.12719714641571045, 0.03240220621228218, 0.02832326665520668, 0.08206745982170105, 0.008289103396236897, 0.010321510024368763, -0.214645117521286, 0.11472037434577942, -0.10026009380817413, -0.20118024945259094, 0.0011014482006430626, 0.09693916887044907, -0.043538063764572144, 0.013180339708924294, -0.06185144931077957, -0.061153918504714966, -0.03132856264710426, -0.03942081332206726, 0.03163265809416771, -0.01052640751004219, 0.03593258187174797, 0.04358142986893654, 0.009685754776000977, 0.1355823129415512, -0.13501539826393127, 0.0816795825958252, -0.0576402023434639, -0.047495245933532715, 0.04321631044149399, -0.10618297010660172, 0.24767577648162842, -0.0053641884587705135, 0.012976993806660175, 0.06142337620258331, 0.03089800849556923, -0.1327265501022339, 0.07441417127847672, 0.04533956199884415, 0.10183874517679214, -0.019732804968953133, -0.11239553987979889, 0.15494512021541595, -0.12393605709075928, 0.04197753220796585, 0.1112382635474205, 0.10086092352867126, -0.021525338292121887, 0.02852635830640793, -0.031715359538793564, 0.0736924335360527, 0.014591338112950325, 0.016646400094032288, -0.005085470154881477, 0.10362095385789871, -0.1073082759976387, -0.1332947313785553, -0.10085664689540863, -0.03615592047572136, -0.10025852918624878, -0.09880383312702179, -0.06595858931541443, -0.0026724794879555702, 0.0074697984382510185, 0.1253589540719986, -0.09959372878074646, 0.06940629333257675, 0.054320916533470154, -0.03407318890094757, -0.0036850017495453358, -0.15959633886814117, 0.04338952153921127, 0.03724677115678787, -1.0029832964164598e-07, 0.1989777684211731, -0.06391151249408722, -0.06452372670173645, -0.05598447471857071, -0.052737072110176086, -0.11210791021585464, 0.040043313056230545, 0.005928625352680683, -0.04072219133377075, -0.001805784646421671, 0.11978568136692047, 0.11274249851703644, -0.02974746562540531, -0.17839014530181885, -0.010670850053429604, -0.07863450050354004, 0.01830081269145012, 0.02939210645854473, 0.009334726259112358, 0.0670255795121193, -0.037490904331207275, -0.062273524701595306, 0.09417659044265747, -0.21059589087963104, 0.030080311000347137, -0.04780895262956619, 0.08989445865154266, -0.034123845398426056, -0.022793222218751907, -0.04709978029131889, 0.004718241281807423, -0.051352351903915405, 0.14297375082969666, 0.16267243027687073, 0.14789560437202454, 0.03519316390156746, 0.07758447527885437, 0.15091824531555176, -0.05929776281118393, 0.15263713896274567, -0.06809374690055847, -0.13899171352386475, -0.07676075398921967, -0.034031886607408524, 0.08501014113426208, -0.022544806823134422, 0.01770784519612789, 0.0911216139793396, 0.16863298416137695, 0.040710799396038055, -0.05259402096271515, 0.07918669283390045, 0.0005233159754425287, -0.08931118994951248, -0.018815698102116585, 0.05271226912736893, -0.09651012718677521, -0.09375273436307907, 0.08119167387485504, -0.13100653886795044, 0.11022854596376419, 0.03256049007177353, -0.00980350747704506, 0.08466576039791107], "changes": {"1wk": 1.6712222412963527}}]